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 Abstract 
This study was undertaken in four phases to evaluate the effect of hyperbaric oxygen 
(HBO) on the repair of critical-sized defects in the presence and absence of a non-
vascularized autogenous bone graft (ABG) and bone graft substitutes namely, 
demineralized bone matrix (DBM) combined with Pluronic F127 (F127) to form a gel or 
putty, or a commercially available biphasic calcium phosphate (BCP), mixed either with 
blood or F127 to form a putty.  A total of 50 New Zealand white rabbits were utilized in 
this study. Phase I utilized 20 animals which were randomly divided into 2 groups of 10 
animals each. Calvarial defects were created in the parietal bones of each animal 
bilaterally. Defects were critical-sized, 15 mm on one side and supracritical-sized, 18 mm 
on the contralateral side. Group 1 received 90-min HBO treatment session at 2.4 absolute 
atmospheric pressure (ATA) per day for 20 consecutive days. Group 2 served as 
normobaric (NBO) controls, breathing only room air. Five animals in each group were 
sacrificed at 6 and 12 weeks. In phase II 20 specimens that were harvested in phase I 
were analysed for the presence of Vascular Endothelial Growth Factor (VEGF) 
expression using immunohistochemical staining. Phase III utilized an additional 10 
animals which were randomly divided into 2 groups of 5 animals each. Bilateral 15 mm 
calvarial defects were created in the parietal bones of each animal. ABG were allocated to 
the left or right defect of each animal. Group1 received HBO treatment while Group 2 
served as NBO controls. All animals were sacrificed at 6 weeks. In phase IV an additional 
20 animals were used which were randomly divided into 2 groups of 10 animals each. 
Bilateral 15-mm calvarial defects were created. Group I defects were grafted with either 
DBM putty or DBM gel. Group II defects were grafted with either BCP or BCP putty. 
Five animals from each group received HBO treatment and 5 animals served as NBO. All 
animals were sacrificed at 6 weeks. 
Calvarial specimens were analysed by plain radiography, micro-computed tomography 
(mCT) and histomorphometry. Both radiographic analysis and histomorphometric 
analysis demonstrated more new bone within HBO-treated defects compared to NBO 
defects (p<.001). There was no significant difference between the percentage of new 
bone forming in the 15-mm and 18-mm HBO-treated defects. VEGF expression in 6 
week HBO samples was elevated compared to NBO (p=0.012). Staining of the 12 week 
HBO samples was reduced compared to 6 week HBO (p=0.008) and was similar to 6 and 
12 week NBO samples. HBO reduced fibrous tissue formation in BCP grafted defects 
and promoted a small but significant increase in bone formation in DBM grafted defects. 
mCT analysis indicated a higher bone mineral density (BMD) and bone mineral content 
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(BMC) in ABG than Non-Grafted defects (p<0.05). Higher BMC (p>.05), bone volume 
fraction (BVF; p>.001), and BMD (p>.001) of the defects grafted with BCP compared 
with DBM grafted defects.  
HBO was effective in enhancing the bony healing of full thickness critical-sized as 
well as supracritical-sized defects in the rabbit calvarial model. However, there was a 
significant decline in the bone mineral content (BMC) of HBO treated grafted defects 
compared to NBO treated grafted defects (p<0.05). HBO enhanced bony healing in non-
grafted rabbit calvarial critical-sized defects and may increase the rate of residual graft 
resorption in ABG and DBM grafted defects. 
 
Keywords: bony defects, bone healing, bone regeneration, calvarial defects, hyperbaric 
oxygen. 
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 Abbreviations 
 
ABG Autogenous Bone Graft 
BCP  Biphasic Calcium Phosphate 
BMC Bone Mineral Content 
BMD Bone Mineral Density 
BMP Bone Morphogenic Protein 
BV  Bone Volume 
BVF Bone Volume Fraction 
CT  Connective Tissue 
DBM Demineralized Bone Matrix 
HA  Hydroxylapatite 
HBO Hyperbaric oxygen 
HBOT  Hyperbaric oxygen therapy  
MB  Mature bone  
MRI  Magnetic Resonance Imaging 
mCT Microcomputed tomography 
NB  New Bone  
NBO Normobaric Room Air Oxygen 
OD  Margin of Original Defect  
ORN Osteoradionecrosis 
RA  Room air 
ROI  Region of Interest 
RT  Radiation therapy 
SD Standard Deviation 
TCP  Tricalcium Phosphate 
TGF-ȕ  Transforming Growth Factor Beta 
TMD Tissue Mineral Density 
TMC Tissue Mineral Content 
VEGF Vascular Endothelial Growth Factor 
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 Glossary of terms 
 
Hyperbaric oxygen: Oxygen at a level higher than atmospheric pressure. 
 
Hyperbaric oxygen therapy: Treatment during which a patient breathes 100% oxygen 
inside a closed chamber pressurized above 1 atmosphere absolute (ATA). 
 
Critical-sized Defect: The smallest full thickness osseous wound that will not heal 
spontaneously during the life time of the subject during the experimental period. 
 
Bone Grafting: A procedure done by reconstructive surgeons to augment volume, 
width or height of deficient or missing bone. 
 
Bone Graft: A material used to augment volume, width or height of deficient or 
missing bone. It can be either autogenous, allogenic, xenogeneic, or alloplastic. 
 
Autogenous Bone Grafting: Transfer of bone harvested from the same individual 
undergoing the bone grafting. 
 
Allogeneic BoneGrafting: Transfer of bone harvested from an individual of one 
species into a different individual of the same species. 
 
Xenogenic Bone Grafting: Transfer of bone between two different species.  
 
Alloplastic Bone Grafting: Transfer of synthetic products. 
 
Radiomorphometrics: The quantitative measurement of areas of radiopacities of bone 
in plain radiographs using a digital image analysis.  
 
Histomorphometrics: The quantitative measurement of different histological elements 
of bone using a digital image analysis.  
 
Microcomputed Tomography Bone Analysis: Analysis of a region of interest in a 
reconstructed three dimensional image for bone mineral density parameters.  
 
Bone mineral content (mg/mm3): Microcomputed tomography based measurement 
of bone mass in the organic matrix. 
 
Bone Mineral Density (BMD): Microcomputed tomography based percentage of 
bone mineral content in the total defect volume. 
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1 Introduction 
Congenital bony defects in the craniofacial and maxillofacial skeleton arise as a 
result of areas of failed development such as in cleft lip and palate patients. Ablative 
surgery may produce bony defects when segments of bones are resected to treat tumors. 
Trauma may result in large boney defects when tissue may have been traumatically 
avulsed. Such osseous defects can be reconstructed using bone grafts, or hopefully, in the 
future with bone graft substitutes. The healing of such wounds relies on the vascularity of 
the affected tissues. 
 
Hyperbaric oxygen (HBO) has been used to aid in the healing of hypoxic or 
compromised wounds (Brown et al., 1998; David et al., 2001; Feldmeier, 2003) such as 
hypoperfused grafts, radiation induced side effects (Bui et al., 2004) and necrotizing 
anaerobic bacterial infections (Larson et al., 2002). Muhonen et al have demonstrated 
that HBO treated rabbits have more osteoblastic activity and osteogenic potential in their 
irradiated distracted mandibles when compared to a non-HBO treated group (Muhonen et 
al., 2002a; Muhonen et al., 2002b). HBO is thought to act by increasing the oxygen 
partial pressure gradient between vessels and interstitial fluids. This results in increased 
wound healing by increasing the amount of oxygen dissolved in the blood (oxygen 
tension) which in turn can increase the amount of oxygen delivered to the hypoxic wound 
site (Shirely and Ross, 2001). HBO can promote angiogenesis (Sheikh et al., 2005) and 
results in an increase in the vessel density in irradiated tissue (Marx et al., 1990). Studies 
have demonstrated that HBO increases bone formation in bone harvest chambers in 
rabbits (Nilsson et al., 1988) and elevates alkaline phosphatase activity, a marker of bone 
formation, in rats following mandibular osteotomy (Nilsson, 1989), and increased 
osteoblastic activity and angiogenesis in irradiated mandibles undergoing distraction 
(Muhonen et al., 2004; Muhonen et al., 2002c). Marx et al. have shown an eight to nine 
fold increase in vascular density with HBO in irradiated tissues (Marx et al., 1985).   
 
HBO’s mode of action in the treatment of decompression sickness and carbon 
monoxide poisoning is well understood based on its effects on reducing gas emboli and 
hastening carboxyhaemoglobin dissociation (Feldmeier, 2003). However, it has also 
demonstrated effectiveness in the treatment of, necrotizing soft tissue infections, soft 
tissue radiation necrosis, diabetic wound healing, and now osseous defect repair where 
other mechanisms are believed to involved (Al-Waili and Butler, 2006; Coulson, 1985). It 
has been well established that the formation of new blood vessels (angiogenesis) is 
essential in the process of soft tissue and bone repair (Bauer et al., 2005; Glowacki, 
1998).  Vascular disruption, caused by traumatic injury has been shown to lead to the 
formation of a hypoxic zone. Wound hypoxia is necessary to stimulate angiogenesis and 
revascularization. HBO increases the amount of oxygen dissolved in the blood (oxygen 
tension) which can in turn increase the amount of oxygen delivered to these hypoxic 
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tissues reducing the effects of the hypoxia (Shirely and Ross, 2001). While this is helpful 
in cases of chronic hypoxia, which blunts the repair process, it is not very clear as to how 
this would stimulate the normal repair process. HBO was shown to be an effective 
adjunct to enhance membranous bone healing and bony union of bony defects (Al-Waili 
and Butler, 2006). HBO treatment also results in increased vascular endothelial growth 
factor (VEGF) protein expression (Bauer et al., 2005). Ex-vivo studies have shown 
elevated titers of alkaline phosphatase activities in HBO treated rabbits (Glowacki, 1998). 
In-vivo studies have also demonstrated increased bone formation in bone harvest 
chambers (Byrne et al., 2005; Klagsbrun and D’Amore, 1991). The need for additional 
grafting may thus be minimized (Marx et al., 1985).  
 
Vascular Endothelial Growth Factor (VEGF) has been identified as one of the 
primary growth factors responsible for neo-vascularization during wound healing and 
embryonic development (Klagsbrun and D’Amore, 1991).  Oxygen tension is a key 
regulator of VEGF expression in vitro and in vivo (Byrne et al., 2005; Nanka et al., 2006; 
Shweiki et al., 1992).  
 
One way to assess the healing of a bony wound is to use a critical-sized defect 
model. A critical-sized defect is by definition the smallest full thickness osseous wound 
that will not heal spontaneously during the lifetime of an animal (Schmitz and Hollinger, 
1986). Such a defect requires an adjunctive technique to permit its complete bony 
healing. The rabbit calvarial critical-sized defect model has been used to study the 
efficacy of a variety of bone substitute materials in promoting defect healing. This model 
was also effective to study cranio-maxillofacial bone regeneration (Clokie et al., 2002; 
Haddad et al., 2006; Moghadam et al., 2004). In the rabbit calvarium, a critical-sized 
defect is defined as a defect 15 mm in diameter (Schmitz and Hollinger, 1986). 
 
Clinically, critical-sized osseous defects may lead to numerous complications 
including fracture, non-union and pseudo-arthrosis (Schmitz and Hollinger, 1986).  
Surgical treatments are utilized to prevent further complications, which may involve the 
use of a fixation device and autogenous bone graft material to bridge the gap in the 
defect.  All such reconstructive procedures that require a second surgical site for the 
harvesting of tissue are associated with potential morbidity (Clokie et al., 2002; Haddad 
et al., 2006; Moghadam et al., 2004). Synthetic biomaterials have been used in place of 
autogenous bone grafts (Moghadam et al., 2004).   
 
Reconstruction of maxillofacial defects aims at restoring form and function. 
Following maxillofacial trauma there is a vascular disruption which leads to the 
formation of a hypoxic zone. While hypoxia is necessary to stimulate angiogenesis and 
revascularization, extended hypoxia will blunt the healing process.  Hypoxia inhibits 
fibroblast proliferation, collagen synthesis and granulation tissue formation (Tandara and 
Mustoe, 2004).  Hyperbaric oxygen therapy (HBO) is the exposure of the patient to 100% 
oxygen at elevated pressures. HBO has been used to improve the healing of a variety of 
compromised or hypoxic wounds including diabetic ulcers, radiation induced tissue 
damage, gangrene and necrotizing anaerobic bacterial infections (Broussard, 2004; 
Fenton et al., 2004; Hunt et al., 2004).  
 
Assessment of bone mineral density (BMD) to determine the quality of bone 
regenerate remains undefined. Quantitative computer tomography has been shown to be 
the most accurate method to measure bone mineral density (Grampp et al., 1997; Weigert, 
1997). It would therefore be useful to evaluate the quality of bone regenerated within 
critical-sized calvarial defects with and without HBO and to compare the quality of bone 
produced in similar defects with a non-vascularized autogenous bone graft by assessing 
BMD using micro CT techniques.  
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The current standard of practice for the treatment of critical-sized defects is the 
use of autogenous bone grafts. Large defects require the harvesting of bone extra-orally 
which requires a second surgical site and results in increased risk of complications 
(Kainulainen et al., 2002b). Smaller defects can be treated with bone grafts obtained 
intra-orally (Kainulainen et al., 2005). Animal studies proved that defects are treatable by 
bone substitutes including demineralised bone matrix, calcium phosphate cements with or 
without bone morphogenic proteins (Clokie et al., 2002; Haddad et al., 2006; Moghadam 
et al., 2004) and fiber-reinforced composites (Tuusa et al., 2007; Tuusa et al., 2008). 
 
This thesis hypothesizes that HBO treatment would promote the healing of a 
rabbit critical-sized calvarial defect, possibly even allowing a supra-critical-sized defect 
to heal.  It also examines the healing of bony defects under hyperbaric and normobaric 
oxygen conditions when the defects are treated with autogenous bone grafts and a variety 
of bone substitutes. 
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2 Review of the literature 
2.1  Biology of Bone Graft Healing 
Three types of bone healing are described: primary, secondary and gap healing. 
The difference between the three is dependent on the size of the osseous defect and the 
rigidity of fixation. The three bone healing models gives different information that relates 
to bone regeneration within non-grafted as well as grafted defects. 
2.1.1  Primary Bone Healing  
Primary bone healing occurs without callus formation when the bone ends are in 
direct contact and rigidly fixated, or anatomically reduced and are compressed together 
by bone plates (Danis, 1949).  This process is usually called contact healing and it was 
initially described after observing radiographs of long bone fractures that were treated by 
plating, it was noticed that they failed to show callus formation. Osteoclasts began to cut 
away cores on either side in the area of compression, progressing towards the fracture. 
The osteoclastic cutting cone proceeded at a rate of 50 to 80 µm per day. Cores were 
200µm which provides space for vessel ingrowth, osteoblastic proliferation and new bone 
formation (Simmons, 1980). Intermediary cartilage is not seen with primary bone 
healing.  
 
Gap healing is another type of primary bone healing. It occurs when a small gap 
exists after rigid fixation. A critical distance of 0.3 mm was thought to be required for 
surviving cells to acquire nutrients from canaliculi at the bone surface and form lamellar 
bone. If the gap was larger than 0.3 mm but up to 1 mm, then woven bone formed first 
and further transformed or remodeled into lamellar bone (Schenk and Willenegger, 1977). 
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2.1.2  Secondary Bone Healing  
Fractures treated without rigid fixation heals with secondary bone healing. A good 
example of non-rigid fixation is maxillomandibular fixation by wiring. The initial injury 
elicits an  inflammatory response and activation o f the complement cascade. Damage to 
blood vessels initiates cellular extravasation and cell signaling. Chemotactic factors (C5a, 
leukotriene B4) attract monocytes and macrophages. Activated macrophages release FGF, 
stimulating endothelial cells to release plasminogen activator and procollagenase. Growth 
factors (PDGF, TGF-β1 and TGF-B2) released from the alpha granules of degranulating 
platelets, are stimulants for PMN, lymphocytes, monocytes and macrophages. The blood 
clot acts as a hemostatic plug, contains the growth factors in the injured site and provides 
an environment for cell s ignaling. The injured t issue i s normally h ypoxic with Oxygen 
partial p ressure o f 5 -10 mmHg as well as acidotic (pH, 4-6). Acidosis and hypoxia are 
required fo r PMN’s an d m acrophages stimulation (Marx e t a l., 1998) . A proliferation 
phase starts the healing by day 3 and can lasts up to 40 days after fracture occurrence. A 
reparative phase f ollows w ith new bl ood ve ssels, c ollagen, a nd c ells. Osteoprogenitor 
cells are then stimulated t o pr oliferate a nd di fferentiate i nto active chondroblasts a nd 
osteoblasts, l aying dow n l arge a mounts o f extracellular m atrices forming a  bridging 
callus. Chondroblasts l ay down extracellular m atrix t hen be come chondrocytes, w hich 
eventually hypertrophy and die, leaving empty lacunae in a calcified matrix. These empty 
spaces ( lacunae) a llow f or va scular i ngrowth r esulting i n a  hi gher ox ygen supply a nd 
normalized pH, which in turn favour differentiation of osteoblasts. The cartilage is then 
removed b y o steoclasts while o steoblasts la y d own immature w oven b one. M obility a t 
the r egenerate site w ill disrupt bl ood s upply and result in  c artilage and f ibrous t issue 
predominance.    
 
2.1.3  Bone Graft Healing  
Three pr ocesses are i nvolved i n t he h ealing of bone  grafts. O steogenesis, 
osteoinduction and osteoconduction (Burchardt, 1983).   
1. Osteogenesis is defined as the formation of new bone from osteocompetent 
cells contained within the bone graft. 
2. Osteoinduction is defined as bone formation from primitive mesenchymal 
cells in the recipient bed, which have been stimulated to differentiate into 
bone forming cells by inductive proteins within the graft. 
3. Osteoconduction is defined as ingrowth of capillaries and osteoprogenitor 
cells from the recipient bed into and around the grafted material. 
 
Various elements o f b one t issue c ontribute t oward t he he aling o f bone grafts 
through the processes of osteogenesis, osteoinduction and osteoconduction, (Gray et al., 
1982). E ndosteum, pe riosteum os teocytes a nd m arrow s paces c ontributes vi a di fferent 
percentages. Gray, Phil and Elves estimated this contribution as:   
1. Endosteum 60% 
2. Periosteum 30% 
3. Osteocytes 10%  
4. Marrow 0%  
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Osteoblasts are immature bone cells responsible for synthesis and secretion of 
osteoid which is rapidly mineralized to form bone. Osteocytes are entrapped osteoblasts 
responsible for the maintenance of the extracellular matrix of bone. Osteoclasts on the 
other hand are large multi-nucleated cells derived from macrophage-monocyte cell lines 
and responsible for the resorptive processes and remodelling of bone. Organic 
Extracellular Matrix is made of inorganic salts namely hydroxylapatite crystals and 
ground substance namely glycoproteins. The extracellular matrix also has a fibrous 
component, the most prominent of which is type I collagen.   
 
Periosteum contains condensed fibrous tissue located on the outer surface of bone. 
The inner layer of the periosteum contains osteoprogenitor cells that have the capability 
to differentiate into osteoblasts. With the exception of the articular surfaces of bone, 
periosteum is bound to bone by Sharpey’s fibers which exist at the sites of insertion of 
tendons and ligaments into bone. Periosteum plays an important role in healing of 
critical-sized defects (Ozerdem et al., 2003). Bone marrow contains dividing pluripotent 
stem cells which are located in the intertrabecular spaces of cancellous bone. Bone 
marrow can be active (Red marrow) or fibrofatty (Yellow marrow), which may be 
reactivated if the need for haemopoiesis arises.  
 
Woven Bone is immature bone with randomly organized collagen fibers. It is 
much coarser than lamellar bone. Woven bone is the first version of bone to form during 
development and also during gap healing of bony defects if the gap is more than 0.3 mm. 
Woven bone continuously remodels over approximately 6 months to form lamellar bone. 
The time needed for transforming woven bone into lamellar bone is known as “Sigma”, 
which is a species specific value. The Sigma for humans is 18 weeks, which explains 
why surgeons wait at least 4 months before applying functional loads to autogenous bone 
grafts. The sigma for rabbits on the other hand, is only 6 weeks (Parfitt, 1976).   
 
Lamellar Bone forms most of the mature skeleton. It comprises a solid mass 
“compact bone” and spongy mass “cancellous bone”. Compact bone has a unique 
physical structure. Bony columns in compact bone are parallel to the axis of stress 
representing concentric bony layers or lamellae. Central channels contain lymphatic 
vessels, blood vessels, nerves and are known as Haversian canals. Volkmann’s canals are 
also neurovascular bundles which interconnect haversian canals at right angles. As 
osteoblasts lay down bone peripherally, they get trapped as osteocytes in lacunae with 
connecting canaliculi. Cytoplasmic extensions within canaliculi connect osteocytes 
together and with osteoblasts as well.  
 
The outermost layers of a bone consist of concentric lamellae of dense cortical 
bone while the inner layer is the medullary aspect. The medullary bone has irregular 
lamellae and trabeculae of spongy bone. Cancellous bone is synonymous with spongy 
bone. The network of irregular bony trabeculae separates the bone marrow spaces from 
each other. Trabeculae are lined by endosteum that is structurally similar to periosteum 
with osteoprogenitor cells, osteoblasts and osteoclasts. Bony lacunae contain osteocytes 
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with canaliculi. Cancellous trabeculae have no haversian systems. Metabolite exchange 
occurs via canaliculi and blood sinusoids in the bone marrow. 
 
Axhausen described autogenous bone grafts as inert collections of transplanted 
bone which eventually loose their vitality and become replaced by new bone through 
neoangiogenesis and cell differentiation (Axhausen, 1907). This process was termed 
creeping substitution.  Others have demonstrated in vivo new bone formation with grafted 
autogenous bone in the muscle pouches of dogs (Ham and Gordon, 1952).  The theory 
that Ham and Gorlin adopted was that some cells survived within the graft and continued 
to grow new bone.  
 
Many investigators described two phases of bone formation in autogenous bone 
graft healing (Axhausen, 1956; Gray and Elves, 1979; Marx, 1993) 
I) Phase I: transplanted cells within the graft formed new bone during the first 
week of healing and continued for approximately four weeks. Nutrition was 
acquired through diffusion from the recipient bed. The amount of new bone 
formed correlated with the number of surviving transplanted cells.   
II) Phase II: Bone formation began in the second week of grafting and peaked 
around the fourth or fifth week.  Phase II continued for life as bone 
remodeling. The graft integrated during this period of remodeling.    
 
2.2  Bone Graft Substitutes 
2.2.1  Allogeneic Demineralized Bone Matrix  
Although allogeneic bone is one of the most commonly used alternative to the 
autogenous harvested bone, it offers the potential risk of disease transmission, rejection, 
and resorption. In the 1960s, Marshall Urist and his coworkers revealed that the 
implantation of acid-demineralized bone into extraskeletal sites led to the development of 
bone ossicles. This phenomenon has become known as osteoinduction (Urist, 1965) a 
process by which a bioimplant stimulates local undifferentiated mesenchymal cells to 
become osteoprogenitor cells, which will eventually form new bone. It is now generally 
accepted that the osteoinductive potential of demineralized bone matrix (DBM) is due to 
endogenous bone morphogenetic proteins (BMPs) that function to signal for embryonic 
bone induction.  
 
Urist hypothesized that BMPs are released from a “supramolecular aggregate of 
noncollagenous proteins” during bone turnover or in injury (Urist, 1989). Mineralized 
bone matrix has no osteoinductivity, and BMPs are hidden by minerals in bone, once 
demineralized, BMPs will be exposed to the appropriate cells. It has been shown that if 
demineralization of the DBM is increased such that the residual calcium content of the 
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DBM falls below 2% by weight, the osteoinductivity of the DBM is lost (Zhang et al., 
1997).  
 
It is hypothesized that remineralisation of bone requires an initial nucleation 
event; by leaving some residual calcified component. Foci of hydroxyapatite (HA) 
facilitate calcium deposition onto its surface and start the mineralization process. 
Therefore, demineralization is a compromise between removing enough of the mineral 
content to expose the BMPs while at the same time leaving a sufficient amount of 
calcified component to facilitate remineralization. Providing calcium ions in the 
microenvironment during mineralization has been shown to be beneficial. The use of 
calcium hydroxide (CaOH) has showed increased mineralization, bone metabolism, total 
protein synthesis, and collagen synthesis (Murakami et al., 1997).  
 
Others have postulated that early remineralization may have an effect on 
stimulating osteogenesis and may improve the osteoinductive potential of DBM 
(Garraway et al., 1998). The effect of CaOH on remineralization of DBM is largely 
unknown. It is clear that CaOH directly placed into a bony defect will not have 
stimulatory effects (Mitchell and Shankwalker, 1958). Particulate DBM has been shown 
to allow for bony healing of critical sized defects. Rabbit DBM grafted into cranial vault 
defects showed 50% to 75% new bone fill at 12 weeks; however, these were not critical 
sized defects (Lindholm et al., 1993). Dogs’ calvarial defects grafted with fresh 
autogenous bone showed 99% bone fill, whereas those filled with DBM showed 77% 
bone fill (Oklund et al., 1986). A number of other studies have supported these findings 
as well and therefore suggest that DBM may be a reasonable alternative to autogenous 
bone (Moghadam et al., 2001; Salyer et al., 1992).  
 
2.2.2  Poloxamer 407   
Particulate DBM can be very technically challenging to use. It is dehydrated fat 
free material. Delivery of DBM in an appropriate vehicle may allow the surgeon to more 
effectively control its placement. Studies have shown that certain carriers may also allow 
for a more effective release of BMPs from the DBM (Clokie and Urist, 2000). One such 
medium is poloxamer 407.  
 
Poloxamer 407 is a reverse-phase block copolymer that, once warmed by body 
fluids, will form a viscous gel and allow for improved handling characteristics (Clokie 
and Urist, 2000). Poloxamers are hydrophobic copolymers with solubility in aromatic 
solvents (Clokie and Urist, 2000; Schmolka, 1972). Poloxamers are commercially used as 
additives, defoamers, anti-static agents, demulsifiers, detergents, gelling agents, 
dispersants, and dye levellers (Clokie and Urist, 2000).  
 
When poloxamer 407 is mixed with DBM or even mineralized bone graft 
substitutes, the resultant bioimplant will harden at the recipient site, making it easy to 
adapt, facilitating surgical application. Due to its molecular structure, poloxamer 407 
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allows for the slow release of an active ingredient (BMP) (Moghadam et al., 2004). When 
poloxamer 407 was evaluated against other delivery agents such as HA, collagen, and 
other noncollagenous proteins, it was found to be superior in its ability to deliver and 
release BMP. 
  
In study IV, a commercially available poloxamer 407 (Pleuronic F-127 ©) was 
mixed with the bioimplants to improve their handling. 
 
2.2.3  Biphasic Calcium Phosphate (BCP)   
Biphasic calcium phosphate (BCP) as an osteoconductive biomaterial may be 
differentiated from its osteoinductive counterpart by its inability to induce new bone 
formation. It assists bone formation by providing a microstructural scaffold that supports 
bone growth throughout its structure. Osteoconductive scaffolds allow chemotactic, 
circulating proteins and cells (e.g. mesenchymal stem cells, osteoinductive growth 
factors) to migrate and adhere, and within which progenitor cells can differentiate into 
functioning osteoblasts (Paderni et al., 2009). Such scaffolds chemically bind and 
integrate with bone, restoring contour and providing strength and support. It is also 
considered biodegradable and eventually is replaced with host bone (Schmitz et al., 
1999).   
 
BCP particles used in this study are comprised of both hydroxyapatite (HA) and 
beta polymorph of tricalcium phosphate (beta-TCP) at 60:40 ratios by volume. 
Microporosity and micropore size of BCP particles have a strong impact on their protein 
adsorption characteristics (Zhang et al., 2010). Porous implants have the potential for 
ingrowth of bacteria that can be introduced at the time of surgery or post-operatively, due 
to tissue breakdown. This occurs when the pore size is less than 1 micron. Human host 
defences including macrophages require a pore size of > 50 microns to enter and engulf 
bacteria that have infected the implant. Therefore, the ideal porous implant would have 
pores smaller than 1 micron to avoid bacterial innoculation or >50 microns to allow 
macrophages to engulf the bacteria (Cohen et al., 1999). 
 
In study IV, a commercial product (Starumann Bone Ceramic ©) was used. Each 
glass vial contained 0.5g with 400 – 700 µm microporosity. The material was mixed with 
either autogenous blood or poloxamer 407 to improve handling. 
2.3  Growth Factors 
Exogenous recombinant growth factors such as bone morphogenic proteins 
(BMPs), play an important role in driving bone regeneration, and give more consistent 
results than the previous bone substitutes. These factors modulate cellular activity and 
provide stimuli to cells to differentiate and produce new bony tissue. 
 
Growth factors include BMPs, fibroblast growth factor (FGF), insulin-like growth 
factor (IGF), platelet-derived growth factor (PDGF), transforming growth factor (TGF), 
and vascular endothelial growth factor (VEGF) (Carter et al., 2000). These factors are 
secreted by the cells involved in the repair process. In the same time, bone itself also 
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constitutes a large reservoir for many growth factors (Colnot et al., 2003). Factors are 
constantly synthesized and stored until remodelling or trauma initiates their release. Once 
released, the growth factors modulate the healing response and mediate the remodelling 
process. Stem cells can be stimulated by growth factors such TG• -1, BMPs or VEGF to 
guide the differentiation and growth of the cells (Sándor and Suuronen, 2008).  
2.3.1  Transforming Growth Factor (TGF) 
The transforming growth factor superfamily members are related to each other by 
relative degrees of sequence similarities. Diverse biological functions are observed 
(Schmitt et al., 1999). TGF-•  release from platelet’s alpha granule degradation was 
extensively studied and proved to be osteoinductive in multiple applications including 
sinus augmentation procedures (Marx et al., 1998). The application of TGF-•  to implant 
sites was found to increase the amount of bone healing and significantly improves the 
implant-bone surface contact (Clokie and Bell, 2003).       
2.3.2  Bone Morphogenic Proteins (BMPs) 
BMP is a subfamily of TGF-•  is made of seven conserved cysteine residues at the 
mature carboxy terminal (Wozney et al., 1999). They are low molecular weight proteins 
(19 to 30 kDa) with a pH of 4.9 to 5.1 (Moghadam et al., 2001; Urist et al., 1975). BMPs 
stimulate mesenchymal stem cells to differentiate into osteoblasts during development 
and bone healing (Ducy et al., 1997; Schmitt et al., 1999). Being present in most tissues, 
they  play an important role in remodeling of the adult skeleton. When osteoclasts resorb 
bone matrix, BMP is released providing recruitment and differentiation of stem cell 
precursors to form new bone (Dragoo et al., 2003).  
BMP-7 is alsp known as osteogenic protein 1 (OP-1), was first used to aid the 
healing of maxillary Lefort I osteotomy by Warnke in 2003 (Warnke and Coren, 2003). It 
is approved for human use in sinus elevation procedures as well in socket preservation 
techniques. The recombinant human form is derived from a recombinant Chinese hamster 
ovary cell line. Laboratory as well as human studies data has shown superior results in 
reconstructing critical-sized defects (Moghadam et al., 2001; Moghadam et al., 2004). 
Clokie and Sándor were first to report the use of OP-1 in post-resection defects. They 
reported 10 cases of post-resection mandibular defects successfully reconstructed with 
BMP-7 (OP-1) in DBM suspended in a reverse phase medium. An uneventful 
postoperative course was reported with dental rehabilitation achieved 1 year post-
reconstruction (Clokie and Sándor, 2008).   
2.3.3  Vascular Endothelial Growth Factor (VEGF) 
Angiogenic signals are crucial to establish new vascular networks, which provide 
the nutrients for tissue growth and homeostasis. Vascular endothelial growth factor 
(VEGF) is one of the most important in bone repair.  Recent studies have shown that 
VEGF also influences osteogenesis and has a direct effect on osteoblasts (Kaku et al., 
2001). Angiogenesis is a prerequisite for bone regeneration. VEGF also found crucial for 
vascular invasion because it stimulates osteoclastic resorption and chondroclastic 
 23 
activities (Engsig et al., 2000; Gerber et al., 1999; Olsen et al., 2000). In particular, 
VEGF may help in patients where the vasculature has been compromised following 
radiotherapy (David et al., 2001). In these patients, the use of hyperbaric oxygen (HBO) 
therapy is necessary to provide enough oxygen to the bone and prevent 
osteoradionecrosis following tooth extraction or bone grafting (Marx et al., 1990). HBO 
therapy enhances wound healing through increased oxygen tension leading to vascular 
proliferation (Shirely and Ross, 2001).  
2.4  Animal Model 
The calvarial critical-sized defect model in rabbit parietal bones has been used by 
a number of authors (Tuusa et al., 2008). This model has proven to be reproducible and 
reliable (Moghadam et al., 2004). Ease of handling was reported by multiple investigators 
(Clokie et al., 2002; Haddad et al., 2006; Moghadam et al., 2004). It provides sufficient 
defect volume that is surrounded by both cortical and cancellous bone resembling 
maxillofacial bone healing module. The one difference compared to other anatomical 
sites is the presence of a pulsatile dural layer in the base of calvarial full thickness 
defects, which is not present in the maxillofacial skeleton for example. (Ozerdem et al., 
2003) 
A Critical-sized defect is best defined as the smallest osseous wound that will not 
heal spontaneously during the experimental period or the life of the animal (Hollinger et 
al., 1994). Host systems induce healing via fibrous union instead. The critical-sized 
defect exceeds the body’s ability to regenerate bone. The quantity of bone regenerated in 
the critical-sized defects is influenced by the animal species, age, anatomic location of 
the defect, size of the defect and finally intactness of periosteum (Schmitz and Hollinger, 
1986).  
Calvarial critical-sized defects receive their blood supply from the pericranium 
and the dura, unlike long bone defects, which have nutrient canals. Intact periosteum as 
well as dura is essential for bone regeneration in full thickness calvarial defects (Ozerdem 
et al., 2003). 
   
2.5  Hyperbaric Oxygen Therapy 
Hyperbaric oxygen therapy is defined as intermittent exposure to 100% oxygen 
under pressures greater than 1 absolute atmosphere (ATA). The concentration of oxygen 
in the atmosphere is 21%. At 1 ATA, the oxygen in blood is almost entirely carried by 
hemoglobin. 97% of oxygen carried in the arterial blood is chemically bound to 
haemoglobin while only 3% is dissolved in plasma. 1 gram of haemoglobin carries a 
maximum of 1.34 ml of oxygen. Fully saturated haemoglobin (100%) in 100ml of blood 
carries approximately 20 ml of oxygen. Hemoglobin that is saturated to 97% carries 
19.5ml of oxygen in 100 ml of blood. This amount is reduced to 5ml of oxygen while 
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passing through capillaries. Increasing the oxygen-carrying capacity of blood by 
increasing hemoglobin saturation is not possible.  
 At the sea level, gas pressure is 760 mmHg or 1 Atmosphere Absolute (ATA). 
Arterial haemoglobin saturation is 97%, while venous haemoglobin saturation is 70%. 
Inhalation of HBO increases the quantity of oxygen dissolved in plasma. At 1 ATA, the 
amount of dissolved oxygen in 100 ml of plasma is 0.449 ml. When inhaling 100% 
oxygen at 1 ATA, O2 concentration increases to 1.5ml / 100 ml of plasma. When inhaling 
100% oxygen at 3 ATA, the amount of dissolved oxygen in 100 ml of plasma increases to 
6.422 ml / 100ml of plasma, which is enough to meet the basic metabolic needs of 
healing tissues in the human body.  
 The driving force for oxygen diffusion from the capillaries to tissues can be 
estimated by the difference between the partial pressure of oxygen on the arterial side and 
the venous side of the capillaries. The difference in the partial pressure of oxygen from 
the arterial side to the venous side of the capillary system is approximately 37 times 
greater when breathing 100% oxygen at 3 ATA than air at 1 ATA. 
 Hyperoxia causes a rapid and significant vasoconstrictive effect. (van Golde et al., 
1999). Breathing 100% oxygen at 3 ATM leads to a reduction in perfusion of up to 25% 
in the brain. This leads to neurotoxic activities in 10% of the population (Gelfand et al., 
2006). Reduction in perfusion also occurs in other tissues, although to a lesser extent.   
 Increasing abnormally low tissue oxygen concentrations has been shown to 
accelerate healing. Fibroblast synthesis of collagen requires tissue oxygen tensions of 30-
40 mm Hg. HBO therapy has the potential to achieve these levels in hypoxic or poorly 
perfused tissues. It was shown in in vitro studies that exposure to HBO for 30 minute and 
60 minute periods at 2.5 ATA enhances fibroblast cell growth. On the other hand, 120 
minute exposure to HBO at 2.5 ATA exerts a marked proapoptotic effect (Conconi et al., 
2003). 
Hyperbaric oxygen (HBO) has been used to aid in the healing of hypoxic or 
compromised wounds (Brown et al., 1998; David et al., 2001; Feldmeier, 2003) such as 
hypoperfused grafts, radiation-induced side effects (Bui et al., 2004) and necrotizing 
anaerobic bacterial infections (Larson et al., 2002). Hyperbaric oxygen therapy has 
proven to stimulate osteoblastic proliferation and differentiation in vitro (Wu et al., 2007). 
Marx and Ehler have shown angiogenic effects of HBO therapy at 2.4 ATA with repeated 
exposures for 90 minutes (Marx et al., 1990). 
2.5.1  History of Hyperbaric Oxygen Therapy 
The development of hyperbaric medicine is closely linked to the history of diving 
medicine. In the first documented use of hyperbaric therapy, the British physician 
Henshaw used compressed air for medical purposes in 1662. In 1775, Joseph Priestly was 
credited with having discovered oxygen. A system for treating diving accident victims 
using HBO was proposed by Drager in 1917, but it was not until 1937 that Behnke and 
Shaw used HBO to treat decompression sickness (Severinghaus, 2003).  
 
Since the 1930s, HBO therapy has been widely used in diving medicine and for 
numerous other medical conditions. The accredited use of HBO is regulated by the 
Undersea and Hyperbaric Medicine Society which update their guidelines periodically. 
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Unfortunately, unproven claims and speculation have made HBO’s role, if any, in the 
treatment of some of these illnesses unclear. Tissues treated with HBO have increased 
levels of oxygen, which in turn have a negative effect on anaerobic bacteria (Fenton et 
al., 2004) and a positive effect on blood flow to the area (Marx et al., 1990). HBO has 
positive effects on osteoblastic activity (Muhonen et al., 2004). HBO reverses hypoxia, 
hypocellularity, and hypovascularity of irradiated tissues (Brown et al., 1998).   
2.5.2  Physics of Hyperbaric Oxygen 
 
In order to understand the physics of hyperbaric oxygen, one should realize that 
the normal pathway of oxygenation is ventilation through pulmonary alveoli followed by 
transport through the vascular system. There is an orderly arrangement of alveolar 
capillaries, the pulmonary venous system, the left atrium, the left ventricle, the systemic 
arterial system and tissue capillaries which finally not only bring blood and nutrients to 
the interstitial space but remove waste metabolites. Pressure gradients govern oxygen 
diffusion in the interstitial space. Partial pressure of oxygen varies from arterial and 
venous circulations. The partial pressure of oxygen in the alveoli (PAO2) equals 104 
mmHg. While the partial pressure of oxygen in arterial blood (PaO2) equals 90 mmHg 
and in the venous blood (PvO2) it equals 40 mmHg. The oxyhemoglobin dissociation 
curve determines the dissociation of oxygen from the hemoglobin molecules as the blood 
components reach the tissues.  
 
The air we breathe, which is room air, consists of 21% oxygen, 79% Nitrogen and 
0.04% carbon dioxide. Air pressure at sea level equals 780 mmHg which is represented 
by one Absolute Atmosphere (ATA). Dalton’s law calculates the total pressure exerted by 
a gaseous mixture as being the sum of the partial pressures of each individual component 
in a gaseous mixture. According to Dalton’s law the partial pressure of oxygen in room 
air equals 160 mmHg at the sea level.  
 
PO2= 780 X 21/100 = 160 mmHg 
 
The pressure of gas in fluids, such as plasma for example, is calculated by 
Henry’s Law 
 
Gas concentration = pressure X solubility coefficient 
 
The solubility coefficient is directly proportional to the temperature of the tissue. 
2.5.3  Administration of Hyperbaric Oxygen 
HBO can be administered through either a mono-place chamber or multi place 
chamber. Both have been used with comparable success in different HBO facilities.  
Hyperbaric oxygen therapy is costly. In the United States, Medicare pays 
approximately 400 US dollars per dive for facilities fee and 125 US dollars professional 
fee, resulting in an expense of 80,000 dollars for a course of 40 treatments (Attinger et 
al., 2008).  The potential cost of a prolonged course of HBO therapy must be weighed 
against savings that may be achieved from improved tissue healing and reduction of 
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amputations and complicated outcomes. Facilities are often scarce. In 1996, 259 
hyperbaric facilities were reported to exist in the United States. Only eleven were 
reported in Canada. In Finland, accredited facilities are available only in larger cities with 
medical centers or academic health science centers. 
Monoplace Chamber  
Monoplace chamber contains compressed oxygen and designed to treat individual 
patients one at a time (Figure 1). This method is less expensive than multiplace chamber. 
The disadvantage is its limited access to patients. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Monoplace chamber can only be utilized to treat one patient at a time. It 
contains compressed oxygen and is designed to treat individual patients one at a time 
Multiplace Chamber 
Multi-place Chamber (Figure 2) contains compressed air while patients are 
breathing 100% compressed oxygen through hoods or masks. Multiple patients can be 
treated at the same time while a trained attendant is monitoring patients in the chamber. 
Although this method is more expensive and needs a full time trained attendant, it is more 
cost effective and can accommodate up to six individual at a time according to the size of 
the chamber. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Multi-place chamber contains compressed room air. Multiple patients can be 
treated simultaneously while a trained attendant is monitoring the patients in the chamber. 
Patients breath 100% compressed oxygen through hoods or masks while sitting in the 
chamber. 
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2.5.4  Indications of Hyperbaric Oxygen Therapy 
The undersea and hyperbaric medicine society (UHMS) has approved the 
following medical indications for HBO therapy (Broussard, 2004): 
1. Air or gas embolism 
2. Carbon monoxide poisoning with or without Cyanide poisoning 
3. Clostridial myositis and myonecrosis (gas gangrene) 
4. Crush injury and compartment syndrome 
5. Decompression sickness 
6. Enhancement of healing in problem wounds 
7. Exceptional blood loss (anemia) 
8. Intracranial abscess 
9. Necrotizing soft tissue infections 
10. Refractory osteomyelitis 
11. Radiation induced necrosis 
12. Compromised skin grafts and flaps 
13. Thermal burns 
 
Hyperbaric oxygen (HBO) has been used to aid in the healing of hypoxic or 
compromised wounds (Brown et al., 1998; David et al., 2001; Feldmeier, 2003) such as 
hypoperfused grafts, radiation-induced side effects (Bui et al., 2004) and necrotizing 
anaerobic bacterial infections (Larson et al., 2002). Hyperbaric oxygen therapy has 
proven to stimulate osteoblastic proliferation and differentiation in vitro (Wu et al., 
2007). Oxygen content in the tissues can be boosted to 81% ±5% of normal tissue after 
20 sessions of HBO (Marx, 1984). Marx and Ehler have shown 9 fold increases in 
neoangiogenesis with HBO therapy at 2.4 ATA for 90 minutes a day for 20 days (Marx et 
al., 1990).   
2.5.5  Osteoradionecrosis (ORN) of the Mandible 
 
One of the most widely accepted and extensively documented indications for 
HBO therapy is its application in the treatment and prevention of osteoradionecrosis 
(ORN) of the mandible. Marx developed the Wilfred-Hall staging Algorithm for 
classifying and treatment mandibular (ORN) and for prophylaxis prior to teeth extraction. 
(Marx et al., 1985)  
Stage I ORN 
Only cortical bone is exposed by a small mucosal ulcer that is commonly necrotic. 
Exposed bone is without other signs and symptoms. Those are treated by 30 HBO 
therapy sessions with no debridement or only minor bony debridement. If the patient 
progresses favourably, give 10 additional HBO2 treatments. 
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Stage II ORN 
Localized ORN with both the cortical and a portion of the underlying medullary 
bone are necrotic. Stage II ORN is usually a non resolving stage I ORN. Those are treated 
by 30 HBO therapy sessions followed by surgical debridement and 10 more post-
operative HBO therapy sessions. Debridement for Stage II ORN ideally maintains 
mandibular continuity. 
Stage III ORN 
 
Diffuse ORN of the mandible. Full thickness of the mandible is necrotic. Stage III 
ORN is usually a non resolving stage I or II. Mandibular continuity can not be 
maintained. Those are treated by a reconstruction protocol. 30 HBO therapy sessions are 
instituted followed by mandibular resection eradicating all necrotic bone followed by 10 
post-resection HBO therapy sessions. Reconstruction follows in delayed fashion. The 
number of HBO sessions varies according to the severity of the condition. 
 
Although there has been controversy regarding the usefulness and the application 
of hyperbaric medicine as an adjunct to bone healing, laboratory data has always been 
convincing. HBO therapy demonstrated an elevation of alkaline phosphatase levels in 
cells derived from alveolar bone. Similar results were also obtained from cells derived 
from irradiated mandibles (Muhonen et al., 2004; Muhonen et al., 2002a). HBO has also 
demonstrated an eight to nine fold increased vascular density over normobaric oxygen 
and air-breathing controls in the irradiated mandible model (Marx et al., 1990). Other in-
vivo studies demonstrated a significant increase in bone formation in the rabbit bone 
harvest chamber (Nilsson et al., 1988). In-vitro studies on the other hand showed 
stimulated osteoblastic proliferation, enhanced bone nodule formation, calcium 
deposition, and alkaline phosphatase activity with daily exposure of HBO to osteoblasts 
in-vitro (Wu et al., 2007). Clinically,  Implant failure in irradiated bone has also been a 
clinical challenge in rehabilitating cancer patients (Granström, 2006). HBO therapy 
demonstrated a significant improvement in osseointegrated implant survival in irradiated 
mandibles (Granström, 2003).   
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3 Aims of the study 
The purpose of this study is to expand the body of knowledge associated with the osseous 
reconstruction of the maxillofacial skeleton and the use of hyperbaric oxygen therapy 
(HBOT). Therefore the specific aims of the study are: 
 
1. To test the effects of hyperbaric oxygen therapy on the healing of osseous critical-
sized and supracritical-sized defects in the rabbit calvarial model. 
 
2. To study the effects of hyperbaric oxygen treatment on the expression of vascular 
endothelial growth factor (VEGF) in a healing osseous wound in the rabbit 
calvarial model. 
 
3. To test the effects of hyperbaric oxygen therapy on the healing of autogenous 
bone grafts in osseous critical-sized defects in the rabbit calvarial model. 
 
4. To test the effects of hyperbaric oxygen therapy on the healing of osseous critical-
sized defects treated with bone substitutes in the rabbit calvarial model. 
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4 Methods and Materials 
4.1 Subjects 
This research project was performed involving a total of 70 rabbits in which the healing 
of their calvarial critical-sized or supracritical-sized defects were the focuses of these 
studies. The work was divided into four studies. The numbers of subjects are listed in 
Table 1. 
Table 1. Number of the subjects included in the four studies. 
 
 Study Number of subjects 
Calvarial 
Defects 
 
I (Hyperbaric oxygen results in an increase in 
rabbit calvarial critical sized defects) 
 
 
 
20 
 
 
40 
 
II (Hyperbaric oxygen results in increased 
vascular endothelial growth factor (VEGF) 
protein expression in rabbit calvarial critical-
sized defects) 
 
20 (from 
Study I) 
 
40 (from 
Study I) 
 
III (Effect of hyperbaric oxygen on grafted and 
nongrafted calvarial critical-sized defects) 10 20 
IV (Effect of hyperbaric oxygen on  
demineralized bone matrix and biphasic 
calcium phosphate bone substitutes) 
20 40 
Total 50 100 
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The protocols to conduct these four studies including anesthesia, surgery, HBO 
administration, sacrifice, data collection and analysis were approved by the animal care 
and research ethics committees of the University of Toronto, Toronto, Canada (Protocol 
Reference Number: 20005155) prior to the commencement of the studies. 
 
4.2 Methods 
4.2.1 Study I: Critical-sized and Supracritical-sized Defects and 
Hyperbaric Oxygen Exposure 
 
 
An animal trial of 12 weeks duration was conducted using 20 New Zealand white 
rabbits, which were randomly divided into 2 groups of 10 animals each. Calvarial defects 
were created in the parietal bones of each animal bilaterally (Figure 3). Defects were 
critical-sized, 15 mm on one side and supra critical-sized, 18 mm on the contra lateral 
side. Group1 received 90 minutes HBO treatment sessions in a chamber specifically 
designed for animal use (Figure 4)at 2.4 ATA per day for 20 consecutive days. Group 2 
served as a control without any HBO treatment sessions. Five animals in each group were 
sacrificed at 6 and 12 weeks. Data analysis included qualitative assessment of the 
calvarial specimens, post sacrifice radiographs and histological sections. Quantitative 
analysis included radiomorphometrics and histomorphometrics to compute the amount of 
regenerated bone within the defects. ANOVA and paired sample t-test were used for 
statistical analysis. 
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Figure 3: Study I surgical protocol. A; Animal is in the prone position, prepped and 
draped. B; Full thickness osseous defect measures 15 mm (critical-sized) on one side and 
18 mm (supracritical-sized) on the contralateral side. C; Pericranium is closed with 4-0 
vicryl. D; Water tight closure for the skin. 
 
 
 
 
 
 
 
 
 
Figure 4: Hyperbaric oxygen chamber 
specially designed for animal research. Rear 
end glass window permits animal 
monitoring using the mirror behind the 
chamber. 
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4.2.2 Study II VEGF Expression and Hyperbaric Oxygen 
Exposure 
 
 This investigation used archived tissue from the previous study from the 20 New 
Zealand white rabbits used in that study. 
 
Qualitative Analysis: Histology 
Following fixation and decalcification, the midpoint of the defect region was identified 
and served as the coronal reference plane of section prior to embedding in paraffin.  
Multiple 6µm sections were cut and stained with hematoxylin-eosin (H&E) for 
conventional light-microscopy. The defect region was visualized in all samples and the 
appearance of new bony regenerate was noted. 
 
Quantitative Analysis: Immunohistochemical analysis 
Multiple 6 µm sections cut from the same paraffin block were used in the histological 
analysis.  These sections were incubated with mouse mono-clonal anti-human VEGF121 
antibody (clone JH-21, Lab Vision Corp, Fermont, CA, USA), with known rabbit cross 
reactivity, as a primary antibody.  Then an avidin-biotin complex (Lab Vision Corp.) was 
incubated to label the primary antibody, and a color reagent was added at the end to allow 
the horse-radish peroxidase reaction to take place.   
 
Analysis of VEGF expression 
Using the image capturing software Image Pro Plus 4.1 for Windows® (Media 
Cybernetics, Carlsbad, CA, USA), 6 random fields from each section were captured at 
40x magnification using an RT Color digital camera (Diagnostic Instruments Inc, Sterling 
Heights, MI, USA). A total of 3 sections were used for each defect resulting in a total of 
18 random images for each right and 18 of each left defect.  The area stained for VEGF in 
each field was measured, by setting a threshold intensity above which a pixel is counted 
using the Image Pro Plus software. 
 
To determine whether there was any difference in the VEGF expression in the center of 
the defects compared to the margins of the defects two images were taken from the 
central one third of the defect with the other 4 being from the margins and their VEGF 
staining measured.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 34 
A B C 
D E F 
4.2.3 Study III Autogenous Bone Grafts and Hyperbaric Oxygen 
Exposure 
 
An animal trial of 6 weeks duration was conducted using 10 New Zealand white 
rabbits, which were randomly divided into 2 groups of 5 animals each. 15 mm critical-
sized calvarial defects were created in the parietal bones of each animal bilaterally. One 
defect was left void. The contralateral defect was grafted with particulate non-
vascularized autogenous bone graft (Figure 5). Group1 received a 90 minute HBO 
treatment sessions at 2.4 ATA per day for 20 consecutive days. Group 2 served as a 
control without any HBO treatment sessions. The animals in each group were sacrificed 
at 6 weeks. Data analysis included micro-CT assessment of calvarial specimens, as well 
as histomorphometric analysis to compute the amount of regenerated bone within the 
defects. 
 
Figure 5: The surgical protocol for Study III. A; Animal is in the prone position, 
prepped and draped. B; Full thickness flap elevated and retracted by self retaining 
retractor. C; A surgical template measured 15x15mm was used to guide the osteotomy. D; 
Full thickness osseous defects created. One side filled with particulate autogenous bone 
graft. E; pericranium closed. F; Water tight closure for the skin. 
 
 
 35 
PUTTY GEL BCP+BLOOD BCP+Pleuronic 127 
Pleuronic 127 
BLOOD 
4.2.4 Study IV Bone Substitutes and Hyperbaric Oxygen 
Exposure 
 
An animal trial of 6 weeks duration was conducted using 20 New Zealand white 
rabbits, which were randomly divided into 4 groups of 5 animals each. 15 mm critical-
sized calvarial defects were created in the parietal bones of each animal bilaterally. 
Group1 received 90 minute HBO treatment sessions at 2.4 ATA per day for 20 
consecutive days and the defects were grafted with allogeneic demineralized bone matrix 
in either a gel or putty state (Figure 6) mixed with resorbable Pluronic F-127 (F127; 
poloxamer 407, BASF Canada Inc., Toronto, Canada). The animals in Group 2 were 
grafted with the same graft substitute materials but without any HBO treatment sessions. 
The defects in the animals in Group 3 were grafted with a bone ceramic mixed with either 
autologous blood or with a combination of the bone ceramic and a resorbable liquid 
poloxamer gel (Figure 7). The animals received 90 minute HBO treatment sessions at 2.4 
ATA per day for 20 consecutive days. The animals in Group 4 were grafted with the same 
graft substitute materials as the animals in Group 3 but without any HBO treatment 
sessions. The animals in each group were sacrificed at 6 weeks. Data analysis included 
micro-CT assessment of calvarial specimens, as well as histomorphometric analysis to 
compute the amount of regenerated bone within the defects. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 6: Defects grafted with 
demineralised bone matrix 
(DBM) in a putty state or gel 
state. 
Figure 7: Defects grafted 
with biphasic calcium 
phosphate mixed with either 
autologous blood or poloxamer 
407 gel.  
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4.2.5 Plain Radiography and Radiomorphometrics 
 
Radiographs of the specimens of all the studies were taken using a cephalostat machine 
standardized for 1:1 magnification on a D speed film at 9mA, 60 KVP for 0.2 seconds.  
The films were processed in an automatic developer and examined for radiopacities, 
which represented new bone formation. Fixation followed in 10% formalin for 48 hours. 
Specimen containers were labelled with a separate coding to allow for blinded analysis.  
Radiographs of specimens of study I were digitized. An investigator blinded to the 
HBO status of the animals traced the areas of radiopacities within the defects. The 
percentages of radiopacities were calculated via Image Pro Plus 4.1 software for 
Windows (Media Cybernetics, Carlsbad, CA).   
4.2.6 Micro-Computed Tomography (mCT) Evaluation and 
Bone Analysis 
48 hours after fixation of specimens of studies III and IV, micro-computed tomography 
(mCT) followed. This study utilized an Explore Locus SP© mCT scanner (GE medical 
systems, London, Ontario, Canada). This scanner was designed to scan specimens that 
measure at most 25 x 30 mm, which corresponds to a bilateral parietal bone specimen 
containing both defects. It was impractical to scan the entire calvarium. Prior to scanning 
the specimens, a calibration scan was performed using a synthetic bone sample, a water 
sample and an air sample. Calvarial specimens were scanned using the fast mode utilizing 
0.05mm sections. Each specimen took 120 minutes to be fully scanned. Reconstruction of 
scanned images (Figure 8) was done using Microview software (GE Medical Systems, 
London, Ontario, Canada) after calibrating the program using the bone, water and air 
standard values.  The reconstructed 3D image was then traced in 3 dimensions to the 
circumference of the original defect margins. This allowed the creation of a 3D 
reconstruction of the defect, which was referred to as the region of interest (ROI).  
 
Figure 8: Micro Computed 
Tomography Coronal sections represent 
a defect traced in multiple sections. 
Tracings were interpolated generating a 
region of interest (ROI) which is shaded 
in yellow. The ROI was analyzed for 
total volume, bone volume, bone mineral 
content, and tissue mineral content.    
 
 
 
 
 
 
 
A reconstructed intact specimen was used to set up the bone value threshold, which 
was analyzed by the same software. A normal distribution curve had determined the bone 
value threshold to be at 1300 at a 95% confidence interval. The bone value was used to 
differentiate bone from non-bone tissues within the defect and to guide the software in 
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measuring tissue mineral content. The region of interest was analyzed using the following 
parameters: 
1- Total Defect Volume (TV) in (mm3)  
2- Bone Volume (BV) in (mm3): Tissues that matched bone value threshold of 1300 
at 95% confidence interval. 
3- Bone Volume Fraction (BVF): Percentage of bone volume by total defect volume 
(BV/TV) 
4- Bone mineral content (BMC) mg/mm3): Measurement of bone mass in the 
organic matrix. 
5- Bone Mineral Density (BMD): Percentage of bone mineral content in the total 
defect volume. 
6- Tissue Mineral Content (TMC) in (mg/mm3): bone mineral content of voxels 
within the ROI. 
7- Tissue Mineral Density (TMD): Percentage of tissue mineral content in the total 
defect volume. 
4.2.5 Histological Evaluation and Histomorphometrics 
Upon completion of the fixation period and radiography,  decalcification followed 
using 45% formic acid and 20% sodium citrate for 4 weeks.  Testing for adequate 
decalcification was accomplished by attempting to cut through a contingency intact 
specimen with a number 10 scalpel. Adequate decalcification was achieved in 4 weeks in 
all of the specimens. Each specimen was sectioned into two portions: an anterior and 
posterior portion. Each half was washed in distilled water for 10 minutes three times. 
Dehydration was accomplished by using a series of alcohol immersions starting with 70% 
ethanol for 15 minutes twice followed by 95% ethanol for 15 minutes twice followed by 
100% ethanol for 30 minutes twice. Each specimen was then immersed in 
methylbenzoate overnight. Immersion in Toluene followed for 30 minutes. Specimens 
were then infiltrated with paraffin embedded under vacuum pressure. Paraffin blocks 
were then sectioned into 7µm sections, prepared and stained with hematoxylin and eosin. 
Sections in the middle of the defects, representing the greatest dimension (15 mm or 18 
mm) were examined under the light microscope by a blinded investigator in an attempt to 
prevent bias.  
Ten sections within the middle of the each of the defects were digitized. Digital images 
were captured by a CCD digital camera (RT Color; Diagnostic Instruments Inc., Sterling 
Heights, MI) attached to the microscope on 4X magnification with 100% zoom to ensure 
proper focus. To create a single image from each slide the digital images were merged 
using Adobe Photoshop Elements 2.0 (Adobe Systems Inc., San Jose, CA). The 
reparative tissues in each defect waer traced and measured by a blinded investigator in an 
attempt to prevent bias. The amount of new bone was extracted and expressed as the 
percentage of the total area of the defect. Calibration was achieved using a millimeter 
grid.   
4.2.6 Statistics 
Simple statistical methods are routinely used in studies involving bone 
regeneration basic research. These methods include descriptive statistics such as the mean 
and its standard deviation for continuous variables, and percentage and sample size for 
categorical variables. Analytical tests such as ANOVA are useful for comparing means 
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with multiple variables, whereas t-tests are most commonly useful for a single variable. 
Paired sample t-test was also useful in comparing defects within individual cohort 
defects.  
The percentage of new bone and the percentage of radiopacities were analyzed in 
relation to either (1) inspired oxygen (HBO vs. NBO), (2) defect size (15 mm vs. 18 
mm), or (3) healing time (6 weeks vs. 12 weeks). The p values below .05 were considered 
to be statistically significant. Results were compared across groups using 1 and 2 way 
ANOVA with Student Newman Keuls (SNK) post hoc testing for normal data of equal 
variance or Holm-Sidak post hoc testing for non-normal/non equal variance data. All 
statistical analyses were performed using either SPSS 10.0 for Windows (SPSS Inc., 
Chicago, IL) or SigmaStat v3.5 (Systat Software San Jose CA). Statistical significance 
was considered to be at p<.05. 
 
In study I, analysis of variance (ANOVA) and paired sample t tests were applied 
in SPSS 10.0 for Windows (SPSS Inc., Chicago, IL), and used to calculate statistical 
differences between the means of new bone formation based on histomorphometrics. 
Means of the radiopacities within the defects were also analyzed. The percentage of new 
bone and the percentage of radiopacities were analyzed in relation to either (1) inspired 
oxygen (HBO vs. NBO), (2) defect size (15 mm vs. 18 mm), or (3) healing time (6 weeks 
vs. 12 weeks). The p values below .05 were considered to be statistically significant. 
 
In study II One-way ANOVA was employed for analysis within and between the 
groups. When differences were found, the Student-Newman- Keuls method was used as a 
post hoc test to determine which groups were significantly different. Comparisons of 
VEGF staining between the 15-mm and 18-mm defects in the same rabbits, and between 
the margins and central regions within each defect, were made using the paired t test. 
Statistical significance was set at p<.05. Statistical analyses were performed using Sigma 
Stat software (v3.0, SYSTAT, San Jose, CA). 
 
In Studies III and IV, All data was tested for normality and equal variance. Results 
were compared across all groups using 1 and 2 way ANOVA with Student Newman 
Keuls (SNK) post hoc testing for normal data of equal variance or Holm-Sidak post hoc 
testing for non-normal/non equal variance data. Paired t-tests were used to compare the 
bilateral defects within animals. As there was bone graft in only two groups in study III, a 
t-test was used to compare the amount of residual graft between the HBO and NBO 
defects which had been grafted with autogenous bone. Statistical analyses were 
performed using SigmaStat v3.5 (Systat Software San Jose CA). Statistical significance 
was considered to be at p<.05. 
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5 Results 
5.1 Critical-sized and Supracritical-sized Defects and Hyperbaric 
Oxygen Exposure 
The Normobaric Room Air Oxygen (NBO) group defects were uniformly 
occupied by a thin membrane of flexible tissue. No dehiscence was noted. The junction 
between this thin flexible membrane and the native bone was clearly demarcated by 
palpation. The dural and the pericranial layers were intact. Appreciable difference was 
noted in the size of the 15 and 18 mm defects as expected. 
The Hyperbaric Oxygen (HBO) group defects were occupied by firmer tissues 
that resemble the hardness of bone. The junction between native bone and the defect 
contents were not palpable. The dural and the pericranial layers demonstrated similar 
appearances as the NBO counterparts   
The radiographs of the NBO defects showed a well demarcated radiolucency with 
noncorticated borders (Figure 9-A). Very small areas of radiopacities were often seen 
within 2 mm from the defect margin, which indicated modest bone formation within 1-2 
mm of the defect margin. No difference was grossly noted between the critical and the 
supracritical-sized defects.  HBO defects showed islands of radiopacities around the 
defect margin extending more than 5 mm toward the center of the defect in the 6 week 
samples, while in the 12 week samples, radiopacities almost approached the center of the 
defect (Figure 9-B).  These islands presented with variable densities. Defect margins 
were still identifiable.    
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Figure 9: Postsacrifice radiographs 
of the parietal bones of A, Normobaric 
(NBO) group animal and B, HBO 
treated group animal. Tracing of 
apparent radiopacities indicates bone 
formation within defects. 
 
 
 
 
 
 
 
 
 
 
Histologically, NBO defects were predominantly filled with fibrous tissue that 
contained an occasional blood vessel. Defect margins were readily identified (Figure 10-
A). New bone was mostly restricted to the defect margins although small islands of 
woven bone were occasionally seen in the fibrous tissue more centrally. The HBO defects 
were completely bridged with bony tissue (Figure 10-B). This bridge consisted of newly 
formed cortical bone with vascular marrow. Defect margins were readily identified. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Histological Sections of HBO and NBO defects. 4X magnification 
hematoxylin and eosin stained sections. A, A normobaric (NBO) control group specimen 
healed primarily with fibrous band of tissue. B, An HBO treated animal sample showing 
bony healing of the defect. 
(HBO = hyperbaric oxygen, NBO = normobaric room air oxygen). 
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5.2 VEGF Expression and Hyperbaric Oxygen Exposure 
5.2.1 Gross appearance and histological evaluation 
Gross analysis of the post-mortem defect size showed the defects of the HBO treated 
groups to be smaller than those of the NBO groups with complete union at 12 weeks in 
all subjects of the HBO therapy group. Histological analysis revealed that healing of the 
defects in the NBO group was mainly by scar formation with only a few bony islands 
scattered along the defect margins. By comparison, the defects from the HBO-treated 
animals contained significant amounts of bone and marrow that completely bridged the 
defects by 12 weeks. The bone in the 6-week HBO defects was predominantly woven, 
but by 12 weeks it tended to be more lamellar in nature (Figure 11). 
Figure 11. Histological appearance of HBO and NBO defects at 6 and 12 weeks. A, 
HBO 6-weeks group. A significant amount of new bone is seen within the defect. B, NBO 
6 weeks group. Although new bone is present within the defect, it is much less than in the 
group treated with HBO. C, HBO 12-weeks group. The entire defect is bridged with new 
bone. D, NBO 12-weeks group. The defects were filled predominantly with dense fibrous 
tissue. CT, connective tissue; MB, mature bone; NB, new bone; OD, margin of original 
defect. (Hematoxylin-eosin stain; magnification x4.) 
5.2.2 Vascular Endothelial Growth Factor (VEGF) staining 
VEGF expression in all groups occurred throughout the fibrous tissue and marrow, 
with more intense staining often seen near bone. When the extent of VEGF staining was 
compared between the 15-mm and 18-mm defects, no differences were detected in any 
group (Table 2) or when considering all the samples as a whole. Consequently, the results 
for the two defects in each animal were averaged to provide one result per animal for 
further analysis.  
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Table 2: Comparison of VEGF staining between 15- and 18-mm defects. 
 
Sacrifice 
time 6 WEEKS 12 WEEKS 
Oxygen HBO  NBO HBO  NBO 
Defect Size 15 mm 18 mm 15 mm 18 mm 15 mm 18 mm HBO NBO 
Mean VEGF 
Expression 
413 571 222 250 167 104 163 145 
+/- SD 171 474 112 137 140 40 71 47 
p value  
(15 vs 18 mm) 
.430 .141 .371 .651 
 
All values are group means +/- SD of the subject means of stained area (µm2) within a field of view. 
Each subject mean represented the average of 6 fields per slide, 3 slides per defect. Each rabbit had one 15-
mm and one 18-mm defect. p values were calculated using the paired t test.  
HBO, hyperbaric oxygen; NBO, normobaric oxygen; VEGF, vascular endothelial growth factor. 
 
The means and standard deviations for the area stained by VEGF for each group are 
reported in Table 3 and displayed in Figures 12,13 and 14. Comparison of the areas 
stained for VEGF between the HBO and NBO groups 6 weeks post-surgery showed that 
there was a significantly greater area staining for VEGF in the samples from HBO-treated 
rabbits (p = .012). Comparison of VEGF staining between the animals sacrificed  at 6 and 
12 weeks postsurgery showed that there was no difference between the two NBO groups; 
however, there was a significant decline in VEGF staining between the 6- and 12-week 
HBO samples (p = .008). 
 
The 12-week HBO and NBO samples had similar amounts of VEGF staining 
(Fig. 5). We also investigated whether there was any detectable difference in the amount 
of VEGF staining between the center and margins of the defect in the 6-week samples. 
However, no differences were detected.  
 
Table 3. Comparison of VEGF staining between HBO and NBO groups. 
 
 
Sacrifice 
time 6 WEEKS 12 WEEKS 
p value  
(6 vs 12 weeks) 
Mean VEGF 
Expression 
HBO 520 +/- 287 147 +/- 38 .008 
NBO 240 +/- 121 149 +/- 76 .630 
p value  
(HBO vs NBO) .012 .987  
All values are group means +/- SD of the subject means of stained area (µm2) within a field of view. Each 
subject mean represented the average of 6 fields per slide, 3 slides per defect, 2 defects per subject (36 
fields measured per subject). Results of the 15- and 18-mm defects were combined in this analysis. P values 
were determined using the Student-Newman-Keuls post hoc test following analysis of variance. 
HBO, hyperbaric oxygen; NBO, normobaric oxygen; VEGF, vascular 
endothelial growth factor. 
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Figure 12. VEGF-stained HBO-treated defects 
at 6 weeks. Rabbits had been exposed to HBO 
therapy (90 minutes at 2.4 atmospheres with 100% 
oxygen) 5 days a week for 4 weeks. Cells stained 
for VEGF were seen throughout the defect. 
However the most intense VEGF staining was 
seen near areas of bone.  
(Magnification x200.) 
 
 
 
 
 
Figure 13. VEGF-stained NBO defects at 6 
weeks. Only low levels of VEGF staining were 
seen throughout the defect. Very few cells were 
seen that stained strongly.  
(Magnification x200) 
 
 
 
 
 
 
 
 
Figure 14. VEGF-stained HBO defects at 12 
weeks. Limited VEGF staining was observed, 
even near areas of bone. 
(Magnification x200.) 
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5.3 Autogenous Bone Grafts and Hyperbaric Oxygen Exposure 
5.3.1 Non-Grafted Defects 
The Non-Grafted defects were uniformly occupied by a thin membrane of flexible 
tissue. No dehiscence was noted. The junction between this thin flexible membrane 
and the native bone was clearly demarcated by palpation. The dural and the pericranial 
layers were intact. The HBO Non-Grafted defects demonstrated similar gross 
morphological features to their Non-Grafted NBO counterparts.  
 
The radiographs of the NBO Non-Grafted defects showed a well demarcated 
radiolucency with noncorticated borders. Very small areas of radiopacities were often 
seen within 2 mm from the defect margin, which indicated modest bone formation 
within 1-2 mm of the defect margin. The HBO Non-Grafted defects were occupied 
with a homogeneous radiopaque shadow. This shadow was denser than what appeared 
in the NBO Non-Grafted defects but still less dense than the grafted defects. Margins 
of the defects were poorly demarcated. 
  
Upon histological examination, the Non-Grafted NBO defects were predominantly 
filled with fibrous tissue that contained an occasional blood vessel. Defect margins 
were readily identified. New bone was mostly restricted to the defect margins although 
small islands of woven bone were occasionally seen in the fibrous tissue more 
centrally (Figure 15). On the other hand, it was difficult to distinguish the defect 
margin in the HBO Non-Grafted treated defects. The defects were completely bridged 
with new bone, which tended to thin towards the centre of the defects, with the dural 
and periosteal edges being composed of denser fibrous tissue. The new bone contained 
marrow elements which were not as extensive as in the grafted defects 
 
5.3.2 Grafted Defects 
The NBO grafted defects were uniformly occupied by firmer tissues that resembled the 
hardness of bone. The junction between native bone and the defect contents were not 
palpable. The dural and the pericranial layers demonstrated similar appearances as the 
Non-Grafted counterparts. The HBO grafted defects demonstrated similar gross 
morphological features to their Grafted NBO counterparts  
 
Radiographically, particles of autogenous bone were clearly visualized within the 
defects with variable densities (Figure 15). NBO Defects margins were still identifiable. 
HBO Defects appeared to be more homogenously radiopaque with less demarcated defect 
borders. Bone graft particles were blended together and less recognizable with more 
homogenous radiopacity. Non-grafted defect was mostly radiolucent in the NBO group 
and mostly radiopaque in the HBO group. Nevertheless, grafted defects showed higher 
degree of radiopacity regardless of the HBO therapy.  
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Figure 15: Plain radiographs of study III specimens showing more radiopacities within 
grafted defects. The HBO non-grafted defect demonstrated denser radiopacity than its 
NBO counterpart.   
HBO, hyperbaric oxygen; NBO, normobaric oxygen 
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Histologically, the NBO grafted defects were completely bridged with bony tissue. 
This bridge was a mixture of non-vital cortical bone from the graft, newly formed bone 
and vascular marrow (Figure 16). Defect margins were readily identified. Meanwhile, 
margins of the defect were difficult to identify in the HBO grafted defects. These defects 
were completely bridged with extensive amounts of new bone and marrow. Minimal 
devitalized remnants of the graft were still visible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Histological Sections of HBO and NBO grafted and non-grafted defects. 
4X magnification hematoxylin and eosin stained sections. A, normobaric (NBO) non-
grafted control group specimen healed primarily with fibrous band of tissue. The NBO 
grafted defects healed with bony bridge. B, An HBO treated animal sample showing bony 
healing of both the non-grafted and the grafted defects. 
HBO, hyperbaric oxygen; NBO, normobaric oxygen 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A (NBO) 
B (HBO) 
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5.4 Bone Substitutes and Hyperbaric Oxygen Exposure 
5.3.1 Demineralized Bone Matrix 
 
Demineralized bone matrix (DBM) grafted defects were uniformly occupied by 
firm tissues that resembled the hardness of bone. The junction between native bone and 
the defect contents were not palpable. The dural and the pericranial layers demonstrated a 
smooth surface with shadow of residual DBM particles. The HBO-DBM grafted defects 
demonstrated similar gross morphological features to their NBO-DBM grafted 
counterparts. No difference was noticed between the DBM gel or putty grafted defects in 
either the HBO or NBO groups.  
 
Radiographically, evidence of radiopacity was clearly visualized within the 
defects with variable densities. NBO Defects margins were still identifiable. HBO 
Defects appeared to be homogenously radiopaque with less demarcated defect borders. 
DBM particles were blended together and less recognizable with more homogenous 
radiopacity (Figure 17). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: Plain radiograph of a study IV specimen grafted with DBM putty in the left 
side and DBM gel in the right side. Radiopacities are noted within grafted defects with 
variable density.   
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Histologically, the grafted defects were completely bridged with bony tissue. This 
bridge was a mainly vital corticocancellous bone with minimal areas of non-vital residual 
bone matrix. Newly formed bone and vascular marrow were observed through out the 
defect (Figure 18). Defect margins were difficult to identify in the grafted defects.  
No difference was noticed between the DBM gel or putty grafted defects in either 
the HBO or NBO groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Histological Sections of bilateral parietal bony defects grafted with 
DBM gel and putty. Bone bridges the entire defect resulting in complete union.  
(Hematoxylin and eosin, [H&E], original magnification x4.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DBM Gel DBM Putty 
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5.3.2 Biphasic Calcium Phosphate 
Biphasic Calcium Phosphate (BCP) grafted defects were uniformly occupied by 
firm tissues that resembled the hardness of bone. The junction between native bone and 
the defect contents were not palpable. The dural and the pericranial layers demonstrated a 
smooth surface with shadow of residual BCP particles. The HBO-BCP grafted defects 
demonstrated similar gross morphological features to their NBO-BCP grafted 
counterparts.  
 
Radiographically, evidence of radiopacity was clearly visualized within the 
defects with intense densities. NBO Defects margins were still identifiable. BCP particles 
were blended together and less recognizable around the defect margins (Figure 19). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Plain radiograph of a study IV specimen grafted with Biphasic Calcium 
Phosphate (BCP) in the right side and BCP putty in the left side. Radiopacities are noted 
within grafted defects with relatively higher density than DBM grafted defects (Figure 
17).   
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Histologically, the grafted defects were completely bridged with bony tissue. This 
bridge was a mixture of vital corticocancellous bone with significant areas of non-vital 
residual BCP. Newly formed bone and vascular marrow were observed through out the 
defect (Figure 20). Defect margins were readily identifiable in the grafted defects.  
No difference was noticed between the BCP or BCP putty grafted defects in either 
the HBO or NBO groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 20: Histological Section of bilateral parietal bony defects grafted with 
BCP and BCP putty. Because of decalcification, the residual graft has been removed and 
so appears as voids in the defect. The defect is completely bridged by bone along its dural 
aspect. New bone and marrow elements are most common at the margins and dural 
aspect, with the tissue along the periosteal aspect being predominantly fibrous in nature.  
(H&E, original magnification of each photomicrograph x4.) 
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5.5 Radiomorphometrics, mCT Evaluation, and 
Histomorphometrics. 
5.5.1 Radiomorphometrics 
Radiomorphometrics were utilized in study I. Findings are presented in table 4 
and graphically shown in figure 21. More islands of radiopacities in the HBO group 
compared to the control group in both the 6- and 12-week specimens (p<.001). There 
were fewer radiopaque foci within the margins of the defects in the control group. In the 
control group the radiopacities tended to blend with the margins of the defects, whereas 
in the HBO group more radiopaque areas were evident both along the margins as well as 
in the center of the defects (Figure 9). No differences were noted between the 15-mm and 
18-mm defects (p=.688). The percentage of radiopacities were greater in HBO samples at 
12 weeks when compared to those at 6 weeks (p=.019). 
 
Table 4: Percentages of radiopacities at 6 and 12 weeks of Critical-sized (15 mm) and 
Supracritical-sized (18 mm) defects  
Sacrifice 
time 6 WEEKS 12 WEEKS 
Defect size 15 mm 18 mm 15 mm 18 mm 
Oxygen HBO NBO HBO NBO HBO NBO HBO NBO 
Percent 
radiopacities 
within 
defects 
52.96 38.31 29.73 29.86 79.51 47.29 95.50 20.39 
27.92 29.46 61.34 41.22 65.41 30.85 76.97 23.16 
60.18 45.72 65.25 43.67 95.13 2.10 92.24 39.02 
57.85 47.39 44.22 26.60 90.35 30.50 98.74 54.07 
44.98 35.84 51.55 29.62 67.03 54.67 74.94 65.88 
Mean 48.78 39.34 34.19 50.42 79.49 33.08 87.68 40.50 
SD 13.03 7.35 14.20 7.69 13.38 20.24 10.97 19.59 
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Figure 21: Bar chart, Radiomorphometrics of study II. More mean percent 
radiopacities within the 15 mm and 18mm defects in the HBO group of phase I study 
(p<.001). More radiopacities were evident at the 12 weeks samples in the HBO group 
(p=.019). 
(HBO = hyperbaric oxygen, NBO = normobaric room air oxygen) 
Data is plotted as mean±SD. 
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5.5.2 Quantitative Micro-Computed Tomography (mCT)  
Micro-Computed Tomography and bone analysis were utilized in study III and IV.  
 
In study III (Table 5 and Figures 22, 23, 24 and 25) statistical analysis indicated 
that the presence of the autogenous graft resulted in increased BV, BMC, BMD and BVF 
compared to Non-Grafted defects under both NBO and HBO (p<.05). Comparisons 
between the HBO and NBO autogenous bone grafted defects revealed that the HBO 
grafted defects had significantly lower BV (p=0.03) and BMC (p<.05). However, the 
reductions in BVF and BMD did not reach significance (p=0.123 and 0.078 respectively). 
No significant differences between the HBO and NBO Non-Grafted defects were seen in 
any of the parameters measured. 
 
Table 5: Micro CT analysis is demonstrated among the study groups and statistically 
analyzed using 1-Way ANOVA  
 NBO HBO 1-Way 
ANOVA 
 Non-
Grafted 
ABG Non-Grafted ABG p value 
between groups 
TV(mm3) 233±37 263±55 191±27 189±66 0.076 
BV(mm3) 41±7 140±22 39±17 87±36 <0.001 
BVF (%) 17.6±2.1 53.9±6.4 20.0±7.3 46.2±11.0 <0.001 
BMC (mg) 31.2±6.3 118.0±21.3 32.4±13.0 76.0±27.6 0.002a 
BMD (mg/mm3) 134±20 451±25 167±53 403±52 <0.001 
TMC (mg) 25.6±4.5 90.3±13.5 23.8±11.3 53.9±24.1 <0.001 
TMD (mg/ mm3)  627±27 645±20 602±26 612±32 0.096 
a Equal variance test failed – p calculated using 1 way ANOVA on Ranks 
 
 
 
Figure 22 : Micro CT 3D 
reconstruct showing the cranial 
side of the parietal bone defects. 
The right side is left to heal 
without grafting and 
demonstrates minimal bone 
formation at the edges at 6 
weeks. The left side id grafted 
with autogenous bone graft and 
found to be completely bridged 
with bone.  
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Figure 23: Bar Chart, Micro CT Results. Bone Mineral Content (BMC). The defects 
containing autogenous bone grafts have significantly higher BMC than the non-grafted 
defects (p<.05). Comparisons between the HBO and NBO autogenous bone grafted 
defects revealed that the HBO grafted defects had significantly lower BMC (p<.05). 
Data is plotted as mean±SD. 
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Figure 24: Bar Chart, Micro CT Results. Tissue Mineral Content (TMC). The 
defects containing autogenous bone grafts have significantly higher TMC than the non-
grafted defects (p<.05). Comparisons between the HBO and NBO autogenous bone 
grafted defects revealed that the HBO grafted defects had significantly lower TMC 
(p=.002) 
Data is plotted as mean±SD. 
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Figure 25: Bar Chart, Micro CT Results. Bone Volume Fraction (BVF). The defects 
containing autogenous bone grafts have significantly higher BVF than the non-grafted 
defects (p<.05). Comparisons between the HBO and NBO autogenous bone grafted 
defects revealed reductions in BVF in HBO grafted defects, however, this did not reach 
statistical significance (p=0.123). No significant differences between the HBO and 
NBO Non-Grafted defects were seen in this parameter.  
Data is plotted as mean±SD. 
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In Study IV (Table 6 and Figures 26 and 27), All parameters were examined for 
significant differences between the different groups using ANOVA (Table 6). Four 
different experimental conditions were compared in this study: BCP versus DBM, HBO 
versus NBO, and two different formulation comparisons of blood versus F127 putty 
within the BCP group and F127 gel versus F127 putty within the DBM group.  
 
Table 6. MicroCT analysis of study IV specimens 
 
 
DBM BCP ANOVA 
p GEL PUTTY BLOOD PUTTY NBO HBO NBO HBO NBO HBO NBO HBO 
Vol 
(mm3) 186+103 161+42 177+95 179+18 162+56 180+30 143+14 128+28 .096 
BV 
(mm3) 67+ 36 62+8 64+ 36 65+10 103+33 111+29 91+9 72+ 21 .017 
BVF 
(%) 35+7 40+7 37+8 34+7 64+4 61+6 64+3 56+8 >.001 
BMC 
(mg) 46+ 23 38+7 41+ 22 41+5 110+36 116+27 84+7 66+19 >.001* 
TMC 
(mg) 29+ 16 25+4 27+16 26+5 107+35 113+29 80+ 7 61+19 >.001* 
BMD 
(mg/mL) 223+34 244+28 232+36 233+27 682+43 641+81 594+52 512+72 >.001 
TMD 
(mg/mL) 
416 
416 + 30 410 + 20 410+4 401+11 563+23 547+21 530+23 506+10 >.001 
 
DBM, demineralized bone matrix; BCP, biphasic calcium phosphate; None, the BCP granules were 
mixed with blood; GEL, the DBM granules were mixed with Pluronic F127 at 40% DBM to 60% F127 
(vol/vol); PUTTY, the DBM or BCP granules were mixed with F127 at 70% DBM/BCP to 30% F127 
(vol/vol); NBO, normobaric oxygen; HBO, hyperbaric oxygen; BV, bone volume; BVF, bone volume 
fraction; BMC, bone mineral content; TMC, tissue mineral content; BMD, bone mineral density; TMD, 
tissue mineral density. 
*Data were not normally distributed and groups were compared using analysis of variance (ANOVA) 
on Ranks. 
 
 
Figure 26: Micro CT 3D 
reconstruct showing the cranial side 
of the parietal bone defects grafted 
with Demineralized Bone Matrix. 
Both sides show complete bridging 
with bone formation across the defect 
with reduced density.   
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Figure 27: Micro CT 3D 
reconstruct showing the cranial 
side of the parietal bone defects 
grafted with Biphasic Calcium 
Phosphate. Both sides show 
complete bridging with bone 
formation across the defect with 
greater density.   
 
 
 
 
 
 
 
 
Following a significant ANOVA result, the matched pairs that were exposed to these 
experimental conditions were tested for significant differences using a post hoc test. For 
comparisons of BCP and DBM, the NBO-BCP-putty was compared with the NBO-DBM-
putty and the HBO-BCP-putty was compared with the HBO-DBM putty (Table 7).  
 
Table 7. Post hoc P values for mCT parameters by matched groups of study IV. 
 Post hoc p values 
 BV1 BVF BMC2 TMC2 BMD TMD 
BCP vs DBM 
Putty-HBO .638 >.001 >.05 >.05 >.001 >.001 
Putty-NBO .098 >.001 >.05 >.05 >.001 >.001 
Blood vs F127 putty 
BCP-HBO .024 .294 >.05 >.05 >.001 .012 
BCP-NBO .459 .991 >.05 NSD .026 .045 
F127 gel vs putty 
DBM-HBO .718 .718 NSD NSD .729 .506 
DBM-NBO .522 .829 NSD NSD .775 .693 
NBO vs HBO 
BCP-blood .661 .671 NSD NSD .206 .232 
BCP-putty .249 .152 >.05 >.05 .015 .087 
DBM-gel .661 .611 NSD NSD .905 .233 
DBM-putty .896 .896 NSD NSD .968 .087 
Following a significant result in the 1-way ANOVA, the matchedvgroups within each of the four 
different experimental conditions (BCP vs DBM, HBO vs NBO and two different formulation 
comparisons blood versus F127 putty with the BCP group and F127 gel versus F127 putty within the 
DBM group) were tested for significant differences using a post hoc test. 
ANOVA, analysis of variance; BV, bone volume; BVF, bone volume fraction; BMC, bone mineral 
content; TMC, tissue mineral content; BMD, bone mineral density; TMD, tissue mineral density; BCP, 
biphasic calcium phosphate; DBM, demineralized bone matrix; NBO, normobaric oxygen; HBO, 
hyperbaric oxygen; NSD, not significantly different. 
1 Following a significant ANOVA test, none of the group comparisons for the BV were found to be 
significant by Student-Newman-Keuls post hoc testing. We therefore used Fisher’s least significant 
difference (LSD) method to identify differences. 
2 p values were not obtained from post hoc testing of non-normal data and are reported as >.05 if they 
were found to be significantly different, or NSD if there were not. 
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ANOVA of the mCT results demonstrated significant differences between the 
groups for all parameters except total volume (Table 6). Identification of the groups that 
had significantly different bone volumes (BV) required use of the Fisher least significant 
differences (LSD) post hoc testing, as SNK was unable to do so. The bone volume was 
higher in the defects grafted with BCP mixed with blood compared with those mixed 
with F127 when exposed to HBO (p<.024) but not for the matching grafts under NBO. 
No other significant differences were seen in this parameter between the various matched 
groups. Defects containing biphasic calcium phosphate had significantly higher BVF, 
BMC, TMC, BMD, and TMD than those containing demineralized bone matrix under the 
same experimental conditions (ie, NBO-putty and HBO-putty) (p<.05).  
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5.5.3 Histomorphometrics 
Histomorphometrics were utilized in studies I, III and IV.  
 
In Study I (Table 8 and Figure 28), histomorphometric analysis demonstrated 
more bone formation in the HBO group when compared to the control group (p<.001). 
Both critical sized (15 mm) and supracritical sized (18-mm) defects healed with 
significantly more bone in the HBO group when compared with the control group. There 
was no significant difference between the percentage of new bone formed in the 15 mm 
and the 18 mm defects (p=.520), nor between the 6-week and 12-week groups (p=.309).  
 
Table 8: Percentages of new bone formation at 6 and 12 weeks of Critical-sized (15 
mm) and Supracritical-sized (18 mm) defects  
 
 
 
 
 
 
 
 
 
 
 
Sacrifice 
time 6 WEEKS 12 WEEKS 
Defect 
size 
15 mm 18 mm 15 mm 18 mm 
Oxygen HBO NBO HBO NBO HBO NBO HBO NBO 
Percent 
new bone 
formation 
64.22 20.63 74.89 30.23 64.02 18.68 58.56 6.84 
49.60 22.77 43.36 45.33 58.06 10.07 52.58 20.03 
67.22 33.26 75.77 46.55 46.67 14.53 57.35 19.90 
53.94 22.64 49.34 24.48 55.39 10.02 50.46 24.16 
47.73 20.01 61.04 22.75 56.67 17.61 39.25 42.26 
Mean 56.54 23.86 60.88 33.87 56.16 21.46 51.64 26.83 
SD 8.74 5.31 14.65 11.37 6.25 18.20 7.67 15.36 
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Figure28: Bar chart, Histomorphometrics New bone formation in study I 
specimens. Differences in the means of new bone formation based on histomorphometric 
measurements in the study groups are demonstrated. More new bone was evident in the 
HBO treated defects (p<.001). 
 
(HBO = hyperbaric oxygen, NBO = normobaric room air oxygen). 
Data is plotted as mean±SD. 
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In study III (Table 9, Figures 29, 30, 21, 32, and 33), histomorphometric analysis 
demonstrated that HBO treated Non-Grafted defects had significantly more new bone 
(p<.001) and marrow (p<.05) and less fibrous tissue (p<.05) than Non-Grafted defects 
exposed to normobaric air. Defects grafted with autogenous bone showed no statistical 
differences in any of the parameters measured. Lesser amount of residual graft was 
present in the HBO compared to HBO defects neared significance (p=0.085) (Figure 32). 
As expected in the normobaric defects, there was significantly more new bone and 
marrow and less fibrous tissue in the grafted defects (p<.05). However comparing the 
Non-Grafted and autogenous bone grafted defects in the HBO treated animals there was 
no significant difference in the amount of new bone (p=0.196), although there was less 
marrow and more fibrous tissue in the Non-Grafted defects (p<.05). 
 
Table 9: Histomorphometric Analysis is demonstrated among the study III groups 
and statistically analyzed using 1-Way ANOVA 
 
NBO HBO 
1-Way 
ANOVA 
Type of 
Tissue (%) 
Non-Grafted ABG Non-Grafted ABG p value  
between groups 
New Bone 19.7±2.6 36.6±8.6 46.7±5.3 41.4±6.9  <0.001 
Marrow 6.3±3.6 37.8±9.1 26.7±9.0 38.7±5.7 0.004a 
B+M 26.0±2.7 74.4±8.1 73.5±12.5 80.1±5.5 0.008b 
Fibrous 74.0±2.7 6.4±1.8 26.5±12.5 8.8±6.1 <0.001b 
Graft N/A 19.1±7.7 N/A 11.2±4.7 0.085c 
a Data not normal, p value generated by 1-way ANOVA on Ranks 
b Data not equal variance, p value generated by 1-way ANOVA on Ranks 
c p value for residual graft was determined by T-test. 
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Figure 29: Bar Chart, Histomorphometry, New Bone Formation in study III 
specimens. HBO treated Non-Grafted defects had significantly more new bone (p<.001) 
than Non-Grafted defects exposed to normobaric air. Comparing the Non-Grafted and 
Autogenous Bone Grafted defects in the HBO treated animals there was no significant 
difference in the amount of new bone (p=0.196).  
Data is plotted as mean±SD 
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Figure 30: Bar Chart, Histomorphometry, Bone Marrow Formation in study III 
specimens. HBO treated Non-Grafted defects had significantly more bone marrow 
(p<.05) than Non-Grafted defects exposed to normobaric air. When comparing the Non-
Grafted and autogenous bone grafted defects in the HBO treated animals, there was less 
marrow in the Non-Grafted defects (p<.05).  
Data is plotted as mean±SD. 
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Figure 31: Bar Chart, Histomorphometry, New Bone Formation and New Bone 
Marrow Formation Combined in study III specimens. Significantly less new bone and 
marrow were observed in the void defects exposed to normobaric air when compared to 
the other 3 types of defects (p=0.008). HBO void defects and grafted defects formed 
comparable amounts of new bone and new marrow.  
Data is plotted as mean±SD. 
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Figure 32: Bar Chart, Histomorphometry, Residual Graft in study III specimens. 
The lesser amount of residual graft present in the HBO compared to NBO defects neared 
significance (p=0.085). 
Data is plotted as mean±SD. 
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Figure 33: Bar Chart, Histomorphometry, Fibrous Tissue Formation in study III 
specimens. Significantly less fibrous tissue (p<.05) was detected in the HBO treated 
defects. Void defects exposed to normobaric air healed mostly with fibrous tissue. 
Data is plotted as mean±SD. 
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In study IV (Table 10), histomorphometric analysis demonstrated that DBM-filled 
defects had significantly more new bone (p<.008) and less residual graft (p<.001) than 
matching BCP-filled defects. Although DBM-filled defects exposed to NBO also had 
increased marrow and reduced fibrous tissue (p<.001 for both), when the BCP defects 
had been exposed to HBO these differences were abolished. These results also correlated 
with an observed increase in marrow and reduction in fibrous tissue in BCP defects 
exposed to HBO compared with BCP-grafted defects under NBO conditions. HBO was 
also seen to lead to a small but significant increase in the amount of new bone in the 
DBM-grafted defects (p<.04). Both marrow and fibrous tissue were reduced in DBM-
grafted defects exposed to HBO; however, this did not reach significance for either tissue 
type. Histomorphometric analysis was unable to note any significant differences between 
groups grafted with different formulations of BCP (blood versus F127) or DBM (gel 
versus putty) in any of the measured parameters. 
 
Table 10. Histomorphometric analysis of study IV specimens 
 
DBM BCP 
ANOVA 
p 
GEL PUTTY BLOOD PUTTY 
NBO HBO NBO HBO NBO HBO NBO HBO 
New 
Bone      36.3
+3.0 43.7+4.9 35.1+5.5 44.3+2.9 22.0+6.9 23.9+3.7 23.6+5.7 24.8+6.6 >.001 
Marrow 47.0+5.2 41.7+7.8 50.6+8.7 43.6+5.6 28.6+4.9 39.1+4.1 29.4+5.5 37.4+5.1 >.001 
New 
Bone + 
Marrow        
83.3+6.1 85.5+3.6 85.8+4.4 87.8+4.4 50.6+8.9 63.0+4.9 53.0+5.5 62.2+7.6 >.001 
Fibrous 
Tissue       13.7
+5.1 9.6+3.3 9.8+2.5 7.1+3.0 25.0+6.4 12.9+5.0 23.1+5.4 13+4.7 >.001 
Residual 
Graft      2.9 
+1.8 5.0 +1.2 4.4 +2.7 5.1 +2.5 24.3+3.0 24.1+5.9 23.9+3.2 24.4+5.4 >.001 
All results are reported as percentage area of defect occupied by tissue type.  
DBM, demineralized bone matrix; BCP, biphasic calcium phosphate; GEL, the DBM granules were 
mixed with Pluronic F127 at 40% DBM to 60% F127 (vol/vol); PUTTY, the DBM or BCP granules were 
mixed with F127 at 70% DBM/BCP to 30% F127 (vol/vol); ANOVA, analysis of variance; NBO, 
normobaric oxygen; HBO, hyperbaric oxygen.  
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6 Discussion 
6.1 Critical-sized and Supracritical-sized Defects and Hyperbaric 
Oxygen Exposure 
One of the major problems encountered by surgeons who deal with large 
craniomaxillofacial defects is the difficulty of maintaining viability within bone graft 
tissue in order to ensure graft survival and eventual restoration of the defect. 
Microvascular reconstructive techniques provide one approach by supplying the graft 
with its own blood supply (Ang et al., 2003). Harvesting such grafts results in significant 
morbidity of the donor site. Free autogenous bone-grafting techniques are associated with 
fewer donor-site complications but still have the limitation of the requirement of an 
adequately vascularized soft tissue bed in order to maintain graft viability. This is a major 
problem in patients who have received radiotherapy and extensive resection in order to 
control a malignant or an aggressive infectious condition (Jisander et al., 1999). 
HBO has been used with success in treating hypoxic wounds and in anoxic 
conditions. Nilsson et al. have shown that HBO treatment would significantly increase 
bone formation in the rabbit bone harvest chamber (Muhonen et al., 2002a; Nilsson et al., 
1988; Sawai et al., 1998). The intent of this study was to evaluate the effects of HBO on 
osseous wound healing and to see if HBO can permit bony repair of critical sized defects.  
The rabbit calvarial defect model is analogous in many ways to clinical 
maxillofacial reconstruction. There is an osseous defect with a periosteal blood supply 
and there is a membranous pattern of bone repair and healing. One difference, however, 
is the presence of a pulsatile dural layer in the base of the rabbit calvarial model, which is 
not present in extracranial maxillofacial wounds.  
A 15-mm defect was used in this animal model and defined as a critical-sized 
defect by Schmitz and Hollinger in 1986 (Schmitz and Hollinger, 1986). This was revised 
by Hollinger and Kleinschmidt in 1990 to be a defect having at most 10% of bony 
healing 10 years postoperatively (Hollinger and Kleinschmidt, 1990). Further increases in 
the size of the defect beyond 18-mm would have required crossing the midline of the 
cranial vault, which posed a significant risk of lethal hemorrhage by potentially violating 
the sagittal sinus. Extending the defect to involve the temporal and the frontal bones 
might have altered the healing due to the involvement of the sutures.  
Based on radiomorphometrics, there was a significant difference in the percentage 
of radiopacities in the HBO group at 6 versus 12 weeks. However, this was not reflected 
in the histomorphometric measurements, where the amount of bone in the defects was 
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unchanged between 6 and 12 weeks. This finding can be explained by the fact that actual 
bone that is demonstrated histologically will not be evident radiographically unless it is 
considerably mineralized.  
Histological evaluation indicated a change in bone from woven to lamellar bone 
between 6 and 12 weeks, which would be expected to result in an increase in the 
radiodensity of the bone. It could be argued that the differences observed between the two 
groups were due to the increased handling of the rabbits in the HBO chamber rather than 
the actual HBO treatment. This is unlikely as the increased handling and confinement in 
the HBO chamber would result in increased stress to the HBO treated animals which 
would in turn be expected to adversely effect healing and not improve it. Further, the 
process of acclimatizing the HBO group of rabbits to the chamber for one week before 
the surgical procedure reduced the discomfort of the rabbits to being confined in the 
chamber and thus minimized stress.  
HBO therapy was applied intermittently to minimize the theoretical blockade of 
hypoxia and lactate induced collagen synthesis and neovascularization (Mainous, 1982), 
(Tuncay et al., 1994) as well as the differentiation of osteoprogenitor cells in the calvarial 
bone marrow and in the periosteal layer of the pericranium and the dura matter (Ozerdem 
et al., 2003). A total of 20 HBO sessions were chosen because neovascularization reaches 
a plateau by 20 sessions (Marx et al., 1985). 
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6.2 VEGF Expression and Hyperbaric Oxygen Exposure 
HBO has been shown to enhance bone repair in bone harvest chambers in the tibia 
and the mandible (Nilsson, 1989; Nilsson et al., 1988); however, the mechanism by 
which this occurs has not been elucidated. It has been reported that HBO can increase 
neovascularization in soft tissue wounds (Broussard, 2004) and the in-growth of new 
blood vessels into the defect is an essential step in bone repair (Glowacki, 1998). VEGF 
and basic fibroblast growth factor (FGF) have been identified as the primary growth 
factors implicated in neovascularization (angiogenesis) in vitro (Klagsbrun and D’Amore, 
1991). However, in vivo, the role of FGF in angiogenesis has been questioned.  
Nissen and coworkers demonstrated that while FGF levels dramatically rise 
immediately after injury, they also return to normal within 3 days, several days prior to 
the onset of angiogenesis (Nissen et al., 1998). Conversely, VEGF increased, peaking at 7 
days postinjury, matching the initiation of angiogenic activity that began after 1 week 
(Denissen and Kalk, 1991). A similar time course for VEGF expression has been reported 
for fracture healing (Komatsu and Hadjiargyrou, 2004). The current study was unable to 
address the effect of HBO on VEGF expression prior to 6 weeks, as this was a 
retrospective study. VEGF expression following trauma in soft tissue and bone has been 
reported to return to normal within 21 days following trauma (Komatsu and 
Hadjiargyrou, 2004; Nissen et al., 1998). Consequently, while we expect that the VEGF 
levels in the NBO-treated animals had been elevated following trauma, they had returned 
to background levels before 6 weeks, explaining the similarity in levels observed between 
the 6-week and 12-week defects in the NBO group. Nevertheless, we were able to 
demonstrate that VEGF levels were elevated 6-weeks following trauma when the rabbits 
had been exposed to HBO.  
It has been shown in a rabbit ischemic ear model that HBO therapy (100% O2; 2.0 
ATA (atmospheres absolute); 90 minutes a day for 14 days) transiently increased tissue 
oxygen partial pressure in the ischemic tissue from hypoxic levels to significantly above 
values seen in NBO non-ischemic tissue. However O2 partial pressure returned to 
ischemic values within 4 hours (Siddiqui et al., 1997). It is possible in our study that the 
cycling between hyperbaric and hypoxic conditions caused by the repeated 90-minute 
treatments of 2.4 atmosphere hyperbaric oxygen exposes the cells of the wound to a 
normoxic or hyperoxic environment at the injured site, removing the hypoxic stimuli for 
VEGF synthesis. However, upon return to normal atmosphere the defects re-experienced 
a hypoxic environment. This change from normoxic to hypoxic conditions may have 
resulted in the continued and prolonged synthesis of VEGF beyond what would occur in 
healing under NBO conditions. While this theory must be tested, there are examples 
where the same stimuli can alter gene expression and tissue formation depending on 
whether it was applied in a constant or cyclic manner. Examples include differences 
between constant and cyclic hydrostatic pressure (Suzuki et al., 2006) and cyclic and 
chronic administration of parathyroid hormone (PTH) (Tam et al., 1982). Sheikh et al., 
using a different HBO protocol (100% O2; 2.1 ATA; 90 minutes, twice per day for 7days), 
demonstrated elevated VEGF levels in a subcutaneous wound cylinder mouse model 
following 7 days of HBO (Sheikh et al., 2000). However, in contrast to our results, they 
reported that VEGF levels returned to baseline within three days of termination of 
treatment. This may have been due to the differences in the HBO protocol, duration of 
treatment, and tissue and/or species studied.  
Another interesting finding was that there was no difference in VEGF expression 
between the two different defect sizes under either of the treatment conditions. It is 
possible that in the NBO group differences may have been observed if we had been able 
to look at earlier stages of healing, prior to VEGF returning to basal levels. In the case of 
the HBO treatments, time of observation may also have been a factor. However, it is also 
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possible that as complete union of both the 15 and 18mm defects did occur at 12 weeks, 
the HBO therapy was able to induce VEGF expression evenly across the whole defect.  
As this study was a retrospective study using archived tissue samples, the study 
was not optimized for quantifying the VEGF expression. Specific shortcomings in the 
study design include that the sample preparation was not optimized for 
immunohistochemical analysis, as samples were fixed in 10% neutral formalin and 
demineralized using formic acid. Second, the time points studied, while useful for 
studying defect repair, did not permit us to investigate the levels of VEGF earlier at 
periods previously seen to have elevated VEGF during normoxic healing and when 
angiogenesis would have been initiated. Third, VEGF exists as multiple isoforms, and 
there is differential expression of these isoforms during healing (Hofstaetter et al., 2004). 
The antibody used in this study was raised against one of the most common isoforms, 
VEGF121, however we do not know it’s cross-reactivity with the other isoforms. 
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6.3 Autogenous Bone Grafts and Hyperbaric Oxygen Exposure 
The current “gold standard” for the treatment of bony defects that are unable to 
heal spontaneously (critical-sized defects) is the use of autogenous bone grafts. However, 
the volume of bone available for grafting is limited and the use of large grafts results in 
significant complications including donor site morbidity, loss of blood, and extended time 
in surgery. HBO therapy has been shown to promote the healing of unfilled critical-size 
defects in rabbits, and may be useful as a replacement for autogenous grafts in certain 
instances and as an adjunct therapy to autogenous bone grafting, minimizing the amount 
of graft required in others. The aim of this study was to evaluate the effect of HBO on the 
healing of critical-sized defects in the presence and absence of autogenous bone grafts in 
comparison to defect healing with grafts under normobaric conditions. This study 
demonstrated that histologically there was significantly more bone (p<.001) and marrow 
(p<.05) in the HBO-treated unfilled defect than the control unfilled defects in untreated 
animals. These results agree with the only other previous study to investigate the effect of 
HBO on critical-size defect healing. Interestingly, we were unable to demonstrate this 
difference by micro-CT, suggesting that the newly formed bone had not yet matured and 
become fully mineralized. Comparison of the amounts of new bone in the HBO-treated 
unfilled defect and the normobaric grafted defect indicated more bone in the HBO group 
that neared significance (46.7 + 5.3 versus 36.6 + 8.6; p<.054). Conversely, there was 
significantly less marrow and more fibrous tissue in the HBO non-grafted defect than the 
NBO grafted defect (marrow: 26.7 + 9.0 versus 37.8 + 9.1; p<.05; fibrous 26.5 + 12.5 
versus 6.4 + 1.8; p<.05).  
When the amount of bone and marrow are considered as a single measure of 
“reparative tissue” the amounts in the HBO unfilled and NBO-grafted defects were 
almost identical (73.5 + 12.5 versus 74.4 + 8.1), with the a volume equivalent to that 
occupied by residual graft in the NBO defects being occupied by fibrous tissue in the 
HBO-treated defects. Histomorphometric comparison of the HBO and NBO defects that 
contained autogenous grafts revealed there were no significant differences, although the 
reduction in the amount of residual graft in the HBO group neared significance (11.2  + 
4.7 versus 19.1 + 7.7; p=.085). However, the micro-CT did show that there was a 
significant reduction in the bone mineral content of the defect (p<.05) and a near 
significant reduction in bone mineral density (p=.078). This can be adequately explained 
by the effect of VEGF on osteoclastic activity within grafted defects. VEGF is found to 
increase osteoclastic and chondroclastic activity within healing bone tissue as part of its 
role in inducing neoangiogenesis (Engsig et al., 2000; Sipola et al., 2006). We think this 
reduction in bone mineral content is only transient and related to increased VEGF levels. 
Tarkka etal, using adenoviral VEGF-A gene transfer, showed a significant hastening of 
endochondral bone formation in the rat femur. They have also shown a transient increase 
in bone mineral content in the VEGF group that normalized within 4 weeks (Tarkka et al., 
2003). However, defects were not critical-sized.   
The difference between the micro-CT and histomorphometric results may indicate 
that there is increased resorption and/or demineralization of the residual graft, which 
would not as easily be detected by histomorphometry. That change, however, was readily 
detected by micro-CT bone analysis. Sawai et al. investigated the effect of HBO on 
mandibular defect healing with autogenous bone grafts in rabbits by histology. They 
reported that HBO increased the amount of bone formed initially and that the graft 
becomes incorporated into the surrounding bone making it difficult to distinguish the 
graft from new bone after 4 weeks, although they did not evaluate the effects 
quantitatively (Sawai et al., 1996). Chen et al demonstrated that HBO increased the rate 
of union of rabbit spinal fusions in the presence of autogenous grafts (Chen et al., 2002). 
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6.4 Bone Substitutes and Hyperbaric Oxygen Exposure 
Bone graft substitutes have been successfully used to treat defects, avoiding some 
of the limitations associated with autogenous bone including donor site morbidity, blood 
loss, and extended time in surgery. HBO has been shown to enhance the bony healing of 
critical-sized defects in rabbits without bone grafting and may be useful as an adjunct to 
bone graft substitutes in smaller defects (Chen et al., 2002; Muhonen et al., 2004). The 
use of HBO as a testing modality may also allow the detection of differences between 
bone and various bone substitute materials that are not evident using other testing 
methods. 
The aim of this study was to evaluate the effect of HBO on the healing of critical-
sized defects in the presence of two commonly used types of bone graft substitutes, 
demineralized matrix (DBM) and biphasic calcium phosphate (BCP). We also 
investigated whether different preparations of these substitutes affected their 
performance.  
Both bone substitute materials were able to promote healing of the critical-sized 
defects. HBO did not significantly increase the amount of bone present in the BCP-
grafted defects compared with defects in animals exposed to normal air. This result 
matches our previous observations where We observed promoted healing and bone 
formation in unfilled defects with HBO, but HBO provided no further increase in bone 
when used in conjunction with autogenous bone grafts. We did, however, observe a small 
but significant increase in new bone with DBM-grafted defects exposed to HBO.  
Exposure to HBO reduced the amount of fibrous tissue in the BCP-grafted 
defects, and showed a matching increase in the marrow component of the repair tissue. 
We have previously demonstrated that HBO treatment results in prolonged increases in 
vascular endothelial growth factor (VEGF) expression, whereas others have demonstrated 
VEGF promotes angiogenesis, bone formation, and remodeling, (Chen et al., 2002; Peng 
et al., 2005; Street et al., 2002) suggesting that that HBO may potentially reduce fibrous 
tissue formation through promotion of angiogenesis, which could result in increased 
marrow. Comparison of the amounts of new bone in the DBM-filled defects and the 
BCP-filled defects indicated more bone and marrow formation in the DBM group 
irrespective of HBO therapy.  
DBM-filled defects also revealed less fibrous tissue formation when compared 
with BCP-filled defects when treated under NBO conditions. We did not see any 
differences in the repair of defects by different preparations of DBM (gel versus putty), 
whereas the different preparations of BCP (blood versus F127) showed some differences 
in mineralization as assessed by the mCT, but not by histology. 
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6.5 Future Perspectives 
 
Our main interest for conducting this investigation was to study the influence of 
Hyperbaric Oxygen (HBO) on the healing of critical sized defects with and without 
additional grafting. Results of this four phase investigation were interesting in light of the 
change in the accepted critical size of full thickness calvarial wound model. We were able 
to demonstrate bony union in critical-sized defects treated with HBO in the absence of 
bone grafting. HBO increases the critical size of the calvarial defect model in rabbits to 
more than 20%. Moreover, the regenerate has new bone quantity that is equivalent to 
autogenous bone grafting 
HBO resulted in a reduction of the bone mineral content of the autogenous bone 
grafted sites. Angiogenesis within the graft may account for the reduction observed 
during the experimental period of this study. The clinical significance if this reduction in 
bone mineral density and bone mineral content has yet to be determined. Further studies 
with higher statistical power and larger sample sizes should be conducted in a load 
bearing model. 
Moreover, testing Demineralized bone matrix and biphasic calcium phosphate as 
a scaffold for adipose derived mesenchymal cells is one of the future directions.  
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7 Summary and conclusions 
 
The following main conclusions can be drawn from the results obtained in the present 
studies: 
 
 
1. The HBOT protocol described in this study effectively enhanced membranous 
bone healing in the rabbit calvarial critical sized defect model. HBOT 
significantly enhanced bone formation within the critical-sized and 
supracritical-sized defects, even in the absence of an autograft or a bone 
substitute, possibly minimizing the amount or totally eliminating the bone graft 
required or bone substitute required to permit healing of the bony calvarial 
defect. 
  
2. HBOT demonstrates an increase in VEGF expression within critical-sized and 
supracritical-sized defects at the 6 weeks time point.  
 
3. HBOT enhanced bony healing in non-grafted calvarial critical-sized defects 
with a bone volume that iwa comparable with autogenous nonvascularized 
bone grafting. HBOT resulted in a reduction of the bone mineral content of the 
autogenous bone grafted sites. Angiogenesis within the graft may account for 
the reduction in BMD observed during the experimental period of this study. 
  
4. HBOT resulted in small increases in new bone formation in defects grafted 
with Demineralized Bone Matrix. In defects grafted with Biphasic Calcium 
Phosphate, HBOT resulted in a significant reduction in fibrous tissue and an 
increase in the replacement of Biphasic Calcium Phosphate with bone marrow.  
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Hyperbaric oxygen results in an increase in rabbit calvarial critical
sized defects
Ahmed M. A. Jan, DDS,a George K. B. Sa´ndor, MD, DDS, PhD, FRCDC, FRCSC, FACS,b
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Objective. This study was undertaken to evaluate whether the effects of hyperbaric oxygen (HBO) therapy could alter the critical
size for spontaneous healing of a bone defect in the rabbit calvarial model.
Study design. An animal trial of 12 weeks duration was conducted using 20 New Zealand white rabbits, which were randomly
divided into 2 groups of 10 animals each. Calvarial defects were created in the parietal bones of each animal bilaterally. Defects
were critical-sized, 15 mm on one side and supraecritical-sized, 18 mm on the contralateral side. Group 1 received a 90-min
HBO treatment sessions at 2.4 absolute atmospheric pressure (ATA) per day for 20 consecutive days. Group 2 served as a control
without any HBO treatment sessions. Five animals in each group were sacrificed at 6 and 12 weeks. Data analysis included
qualitative assessment of the calvarial specimens, post-sacrifice radiographs, as well as histomorphometric analysis to compute
the amount of regenerated bone within the defects. ANOVA and paired sample t test were used for statistical analysis.
Results. Both radiographic analysis and histomorphometric analysis demonstrated that HBO-treated animals had significantly
more new bone within their defects compared with the control group (P\ .001). There was no statistically significant difference
between the percentage of new bone forming in the 15-mm and 18-mm HBO-treated defects. There was no difference between
the 6-week and the 12-week HBO-treated groups. HBO is effective in enhancing the bony healing of full thickness critical sized
as well as supraecritical-sized defects in the rabbit calvarial model.
Conclusion. Bone regeneration was significantly greater in the HBO-treated animals regardless of the defect size. HBO may
have increased the diameter of the rabbit critical-sized calvarial defect to more than 18 mm.
(Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:144-9)
Vol. 101 No. 2 February 2A critical-sized defect is by definition the smallest full
thickness osseous wound that will not heal spontane-
ously during the lifetime of an animal.1 Such a defect
requires an adjunctive technique to permit its complete
bony healing. The rabbit calvarial critical-sized defect
model has been used to study the efficacy of a variety of
bone substitute materials in promoting defect healing.2,3
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Volume 101, Number 2 Jan et al. 145compared to a non-HBOetreated group. Consequently
we hypothesized that HBO treatment would promote
the healing of a rabbit critical-sized calvarial defect, pos-
sibly even allowing a supra-critical sized defect to heal.
MATERIALS AND METHODS
Animals
Twenty adult, skeletally mature, male New Zealand
White rabbits weighing 3 to 4 kg were randomly divided
into 2 groups of 10 animals. Group 1 was treated with
HBO, while group 2 served as a control and did not re-
ceive any supplemental oxygen. Five animals from each
group were sacrificed at 6 and 12 weeks.
Surgical procedures
The surgical protocol for this study was approved by
the University of Toronto Animal Care and Ethics Com-
mittee (Protocol number 20005145). The surgical tech-
nique and analgesic and antibiotic protocols have been
previously described.2,3 Each animal had bilateral full
thickness calvarial defects created in its parietal bones.
Defects were allocated randomly as critical-sized, 15
mm on one side and a supraecritical-sized, 18 mm on
the contralateral side (Fig. 1). Standardization of defects
was accomplished by using a trimmed template of the
desired size. Wound closure was performed in layers.
HBO sessions
The 20 animals in group one (n = 10) underwent a
90-min HBO session at 2.4 absolute atmospheric pres-
sure (ATA) per day 5 days a week for 4 weeks (20 days
total). Pressurization and depressurization were done
at a very slow rate (0.2 ATA per minute) in order to avoid
barotrauma and potential discomfort. The control group,
group 2 (n = 10) had no HBO sessions, breathing normo-
baric oxygen (NBO), otherwise referred to as ambient
Fig. 1. Critical- (15 mm) and supraecritical- (18 mm) sized
defects created in the rabbit parietal bones.pressure roomair, during the entire experimental period.
HBO treatment sessions were begun 24 hours postoper-
atively in a monoplace chamber specially designed for
small animal use. The test group was acclimatized to the
HBO chamber one week preoperatively. This involved
the animals being placed in the unpressurized hyperbaric
chamber for 90 min/day for 5 days. The chamber had
a glass window in its rear allowing the investigator to
monitor the rabbits’ behavior and comfort throughout
the 90-min sessions. Pressurization and depressuriza-
tion were done at a constant slow rate of 0.2 ATA/min
in order to avoid barotrauma and potential discomfort.
Sacrifice and qualitative evaluation
Five animals from each group were sacrificed 6 weeks
postoperatively and 5 from each group were sacrificed
12 weeks postoperatively. The parietal bones were
divided from the rest of the cranium with an oscillating
saw, carefully maintaining the intactness of the pericra-
nium and the dura matter. Specimens were examined
grossly for signs of inflammation, transilluminated, pho-
tographed, radiographed with a cephalostat (Fig. 2), and
then fixed in 10% buffered formalin solution for 3 days
before proceeding with the histological preparations.
Radiomorphometrics
Radiographs were digitized. An investigator blinded
to the HBO status of the animals traced the areas of
radiopacities within the defects. The percentages of radi-
opacities were calculated via Image Pro Plus 4.1 soft-
ware for Windows (Media Cybernetics, Carlsbad, CA).
Histological evaluation
The specimens were decalcified using 45% formic
acid and 20% sodium citrate for 4 weeks. The right
and left parietal bones were separated through the
Fig. 2. Postsacrifice radiograph showing defects bilaterally in
the parietal bones.
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146 Jan et al. February 2006Table I. Percent radiopacities within the HBO (test) and NBO (control) defects
Sacrifice time
6 Weeks 12 Weeks
Defect size
15 mm 18 mm 15 mm 18 mm
Oxygen HBO NBO HBO NBO HBO NBO HBO NBO
Percent radiopacities
within defects
52.96 38.31 29.73 29.86 79.51 47.29 95.50 20.39
27.92 29.46 61.34 41.22 65.41 30.85 76.97 23.16
60.18 45.72 65.25 43.67 95.13 2.10 92.24 39.02
57.85 47.39 44.22 26.60 90.35 30.50 98.74 54.07
44.98 35.84 51.55 29.62 67.03 54.67 74.94 65.88
Mean 48.78 39.34 50.42 34.19 79.49 33.08 87.68 40.50
SD 13.03 7.35 14.20 7.69 13.38 20.24 10.97 19.59
SE 5.83 3.29 6.35 3.44 5.98 9.05 4.90 8.76
Defects measured by calculating areas of radiopacities within the individual defect divided by the total defect area and multiplied by 100, with standard deviation (SD)
and standard error (SE).
HBO, hyperbaric oxygen; NBO, normobaric oxygen.midline sagittal suture. Each bone was further sectioned
into two portions: an anterior and posterior portion.
Both portions were embedded in paraffin blocks. Then
7-lm sections were sliced and stained with hematoxylin
and eosin. Sections in the middle of the defects, which
corresponded to the greatest defect dimension (15 mm
or 18 mm) were examined under the light microscope.
Fig. 3. Postsacrifice radiograph of the parietal bone of A,
HBO-treated group animal and B, control group animal.Histomorphometrics
Digital images were captures by a CCD digital cam-
era (RT Color; Diagnostic Instruments Inc., Sterling
Heights, MI) attached to the microscope on 43 magni-
fication with 100% zoom to ensure proper focus. To cre-
ate a single image from each slide the digital images
were merged using Adobe Photoshop Elements 2.0
(Adobe Systems Inc., San Jose, CA).
The repair tissue in each defect was measured by a
blinded investigator. The amount of new bone was deter-
mined as the percentage of the total area of the defect.
Calibration was achieved using a millimeter grid. Five
randomized sections from each sample were analyzed
in an attempt to prevent bias.
Statistical analysis
ANOVA and paired sample t tests were applied in
SPSS 10.0 for Windows (SPSS Inc., Chicago, IL), and
used to calculate statistical differences between the
means of new bone formation based on histomorpho-
metrics. Means of the radiopacities within the defects
were also analyzed. The percentage of new bone and
the percentage of radiopacities were analyzed in relation
to either (1) inspired air (HBO vs. NBO), (2) defect size
(15 mm vs. 18 mm), or (3) healing time (6 weeks vs. 12
weeks). The P values below .05 were considered to be
statistically significant.
RESULTS
Qualitative findings
All 20 rabbits tolerated the anesthesia and the surgical
procedures well and experienced no complications dur-
ing the experimental period. HBO sessions were un-
eventful in the experimental group. Upon sacrifice,
gross examination of the dissected specimens of the cal-
varia showed no difference between the HBO group and
the control group or between the 15-mm and 18-mm
OOOOE
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Sacrifice time
6 Weeks 12 Weeks
Defect size
15 mm 18 mm 15 mm 18 mm
Oxygen HBO NBO HBO NBO HBO NBO HBO NBO
Percent new bone formation 64.22 20.63 74.89 30.23 64.02 18.68 58.56 6.84
49.60 22.77 43.36 45.33 58.06 10.07 52.58 20.03
67.22 33.26 75.77 46.55 46.67 14.53 57.35 19.90
53.94 22.64 49.34 24.48 55.39 10.02 50.46 24.16
47.73 20.01 61.04 22.75 56.67 17.61 39.25 42.26
Mean 56.54 23.86 60.88 33.87 56.16 21.46 51.64 26.83
SD 8.74 5.31 14.65 11.37 6.25 18.20 7.67 15.36
SE 3.91 2.41 6.55 5.08 2.80 7.43 3.44 6.27
Percent new bone formation measured by calculating areas of new bone formed within the individual defect divided by the total defect area and multiplied by 100,
with standard deviation (SD) and standard error (SE).
HBO, hyperbaric oxygen; NBO, normobaric oxygen.defects in terms of signs of inflammation and integrity of
the healing wound.
Radiomorphometrics (Table I)
Radiographs demonstrated more islands of radiopac-
ities in the HBO group compared to the control group
(Figs. 3 and 4) in both the 6- and 12-week specimens
(P\ .001). There were fewer radiopaque foci within
the margins of the defects in the control group. In the
control group the radiopacities tended to blend with
the margins of the defects, whereas in the HBO group
more radiopaque areas were evident both along the mar-
gins as well as in the center of the defects (Fig. 3). No
differences were noted between the 15-mm and 18-mm
defects (P = .688). The percentage of radiopacities
were greater in HBO samples at 12 weeks when com-
pared to those at 6 weeks (P = .019).
Histological evaluation
The healing of the defects in the control group was
mainly by scar formation. There were a few bony islands
scattered along the defect margins, which might have re-
sulted from bone debris produced by drilling through
bone. The healing of the HBO group produced a tissue
regenerate with many blood vessels and cellular marrow
spaces. The 12-week HBO samples tended to have more
mature, trabecular bone whereas the 6 week samples had
more woven bone and less trabeculated chunks of bone.
Histomorphometrics (Table II)
Histomorphometric analysis demonstrated more bone
formation in the HBO group when compared to the
control group (P\ .001). Both critical- (15 mm) and
supraecritical- (18-mm) sized defects healed with sig-
nificantly more bone in the HBO group when compared
with the control group. There was no significant differ-
ence between the percentage of new bone formed in the
15-mm and the 18-mm defects (P = .520), nor between
the 6-week and 12-week groups (P= .309). (Figs. 5 and 6).DISCUSSION
One of the major problems encountered by surgeons
who deal with large craniomaxillofacial defects is the
difficulty of maintaining viability within bone-grafted
tissue in order to ensure graft survival and eventual
restoration of the defect. Microvascular reconstructive
techniques provide one approach by supplying the graft
with its own blood supply.12 Harvesting such grafts
results in significant morbidity of the donor site. Free au-
togenous bone-grafting techniques are associated with
fewer donor-site complications but still have the limita-
tion of the requirement of an adequately vascularized
soft tissue bed in order to maintain graft viability. This
is a major problem in patients who have received
radiotherapy and extensive resection in order to control
a malignant or an aggressive infectious condition.13
HBO has been used with success in treating hypoxic
wounds and in anoxic conditions. Nilsson et al. have
shown that HBO treatment would significantly increase
Fig. 4. Bar chart showing the differences in the mean radio-
pacity measurements within defects in the study groups
(HBO = hyperbaric oxygen, NBO = normobaric oxygen).
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148 Jan et al. February 2006Fig. 5. 43 magnification hematoxylin and eosin stained sections. A, A control group specimen healed primarily with fibrous band
of tissue. B, An HBO-treated animal sample showing bony healing of the defect.bone formation in the rabbit bone harvest cham-
ber.11,14,15 The intent of this study was to evaluate the
effects of HBO on osseous wound healing and to see
if HBO can permit bony repair of critical sized defects.
The rabbit calvarial defect model is analogous in many
ways to clinical maxillofacial reconstruction. There is an
osseous defect with a periosteal blood supply and there is
a membranous pattern of bone repair and healing. One
difference, however, is the presence of a pulsatile dural
Fig. 6. Bar chart showing the differences in the means of new
bone formation based on histomorphometric measurements in
the study groups (HBO = hyperbaric oxygen, NBO = normo-
baric oxygen).layer in the base of the rabbit calvarial model, which is
not present in extracranial maxillofacial wounds.
A 15-mm defect was used in this animal model and
defined as a critical-sized defect by Schmitz and
Hollinger in 1986.1 This was revised by Hollinger
and Kleinschmidt in 1990 to be a defect having at most
10% of bony healing 10 years postoperatively.16 Further
increases in the size of the defect beyond 18-mm would
have required crossing the midline of the cranial vault,
which posed a significant risk of lethal hemorrhage by po-
tentially violating the sagittal sinus. Extending the defect
to involve the temporal and the frontal bones might have
altered the healing due to the involvement of the sutures.
Based on radiomorphometrics, there was a significant
difference in the percentage of radiopacities in the HBO
group at 6 versus 12 weeks. However, this was not re-
flected in the histomorphometric measurements, where
the amount of bone in the defects was unchanged
between 6 and 12 weeks. This finding can be explained
by the fact that actual bone that is demonstrated histolog-
ically will not be evident radiographically unless it is
considerably mineralized. Histological evaluation indi-
cated a change in bone from woven to lamellar bone
between 6 and 12 weeks, which would be expected to
result in an increase in the radiodensity of the bone.
It could be argued that the differences observed
between the two groups were due to the increased
handling of the rabbits in the HBO chamber rather
than the actual HBO treatment. This is unlikely as the
OOOOE
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ber would result in increased stress to the HBO treated
animals which would in turn be expected to adversely
effect healing and not improve it. Further, the process
of acclimatizing the HBO group of rabbits to the cham-
ber for one week before the surgical procedure reduced
the discomfort of the rabbits to being confined in the
chamber and thus minimized stress.
HBO therapy was applied intermittently to minimize
the theoretical blockade of hypoxia and lactate induced
collagen synthesis and neovascularization17,18 as well as
the differentiation of osteoprogenitor cells in the calvar-
ial bone marrow and in the periosteal layer of the
pericranium and the dura matter.19 A total of 20 HBO
sessions were chosen because neovascularization
reaches a plateau by 20 sessions.20
CONCLUSIONS
The HBO treatment protocol described in this study
seems to be an effective measure to enhance membra-
nous bone healing in the rabbit calvarial critical sized
defect model. The results reported here suggest that
HBO treatment sessions as in the protocol described in
this study significantly enhance bone formation within
the critical-sized defect, even in the absence of an
autograft or a bone substitute, possibly minimizing the
amount or eliminating totally the bone graft required
or bone substitute required to permit healing of the
bony calvarial defect.
HBO may also increase the osteogenic, osteoinduc-
tive, and osteoconductive properties of bone regenera-
tion materials indirectly by promoting early
angiogenesis or by the genesis of a more viable soft
tissue and hard tissue graft recipient wound for such
materials. The rabbit calvarial critical-sized defect
model is suitable for assessing the effectiveness of
HBO therapy on cranio-maxillofacial bone repair and
may be suitable for examining the effect of HBO in
combination with various grafting materials or bone
substitutes in the future.
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Background. Hyperbaric oxygen therapy (HBO) promotes osseous healing, however the mechanism by which this
occurs has not been elucidated. HBO may promote angiogenesis, which is vital for bone healing. Vascular endothelial
growth factor (VEGF) is one of the key factors that stimulates angiogenesis.
Objective. The objective of this study was to investigate whether HBO altered VEGF expression during bone healing.
Methods and materials. Archived samples from calvarial defects of rabbits exposed to HBO (2.4 ATA, 90 minutes a
day, 5 days a week for 4 weeks) and normobaric oxygen controls (NBO) were analyzed by immunohistochemistry.
Results. VEGF expression in 6-week HBO samples was elevated compared to NBO (P  .012). Staining of the 12-
week HBO samples was reduced compared to 6-week HBO (P  .008) and was similar to 6- and 12-week NBO
control samples.
Conclusion. HBO therapy resulted in increased VEGF expression in the defects even 2 weeks after the termination of
treatment (6 weeks postsurgery). (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:417-22)A critical-sized osseous defect is defined as the mini-
mum dimension of a bony lesion that cannot repair
itself to its preinjured state without intervention during
an individual’s life span.1 In the rabbit calvarium this is
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doi:10.1016/j.tripleo.2007.07.015defined as a defect 15 mm in diameter. Critical-sized
osseous defects may lead to numerous complications
including fracture, non-union and pseudo-arthrosis.2
Surgical treatments prevent further complications,
which may involve the use of a fixation device and
autogenous bone graft material to bridge the gap in the
defect. All such reconstructive procedures that require a
second surgical site for the harvesting of tissue are
associated with potential morbidity.3,4 Synthetic bio-
materials have been used in place of autogenous bone
grafts.5 Recently, Jan et al.,6 using the rabbit critical-
sized calvarial defect model, showed that 20 treatments
of 90 minutes of hyperbaric oxygen (HBO) at 2.4
atmospheres could heal both critical-sized and supra-
critical-sized calvarial defects when compared to nor-
mobaric oxygen controls (NBO). This suggests that
HBO has the potential to augment bony healing.
HBO’s mode of action in the treatment of decompres-
sion sickness and carbon monoxide poisoning is well
understood based on its effects on reducing gas emboli
417
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ever, it has also demonstrated effectiveness in the treat-
ment of necrotizing soft tissue infections, soft tissue radi-
ation necrosis, diabetic wound healing, and now osseous
defect repair where other mechanisms are believed to
involved.8,9 It has been well established that the formation
of new blood vessels (angiogenesis) is essential in the
process of soft tissue and bone repair.10,11 Vascular dis-
ruption, caused by traumatic injury has been shown to
lead to the formation of a hypoxic zone. Wound hypoxia
is necessary to stimulate angiogenesis and revasculariza-
tion. HBO increases the amount of oxygen dissolved in
the blood (oxygen tension) which can in turn increase the
amount of oxygen delivered to these hypoxic tissues re-
ducing the effects of the hypoxia.7 While this is helpful in
cases of chronic hypoxia, which blunts the repair process,
it is not so clear as to how this would stimulate the normal
repair process.
Vascular endothelial growth factor (VEGF) has been
identified as one of the primary growth factors respon-
sible for neovascularization during wound healing and
embryonic development.12 Oxygen tension is a key
regulator of VEGF expression in vitro and in vivo.13-15
We therefore wished to investigate the effect of HBO
on VEGF expression in bone healing.
METHODS AND MATERIALS
Experimental design
This investigation used archived tissue from a pre-
vious study.6 The surgical protocol for the study was
approved by the University of Toronto Animal Care
and Ethics Committee (Protocol number 20005145). A
total of 21 skeletally mature male New Zealand white
rabbits were divided into 2 groups (n  10 for the
6-week group, n  11 for the 12-week group). Five
animals in the 6-week group received hyperbaric oxy-
gen treatment (HBO) and 5 control rabbits were kept in
a normobaric environment (NBO). Similarly, 5 rabbits
in the 12-week group received hyperbaric treatment
(HBO) while 6 control animals were exposed to a
normobaric environment (NBO). Critical-sized calvar-
ial defects of 15 mm and supra critical-sized defects of
18 mm were randomly assigned to the right and left
parietal bones of the rabbits and created using a straight
fissured bur guided by a template. For the HBO treat-
ment group, each rabbit was placed into an animal
hyperbaric oxygen chamber and exposed to 100% O2
under 2.4 atmospheres of pressure, for 90 minutes a
day, 5 days a week for 4 weeks (20 treatments). The
rabbits were sacrificed 6 weeks or 12 weeks postsur-
gery and the parietal bones were harvested. These sam-
ples were fixed with 10% formalin and decalcified in a
solution of 45% formic acid in 0.2 M sodium citrate.Qualitative analysis: histology
Following fixation and decalcification, the midpoint
of the defect region was identified and served as the
coronal reference plane of section prior to embedding
in paraffin. Multiple 6-m sections were cut and
stained with hematoxylin and eosin (H&E) for conven-
tional light-microscopy. The defect region was visual-
ized in all samples and the appearance of new bony
regenerate was noted.
Quantitative analysis: immunohistochemical
analysis
Multiple 6-m sections cut from the same paraffin
block were used in the histological analysis. These
sections were incubated with mouse monoclonal anti-
human VEGF121 antibody (clone JH-21, Lab Vision
Corp, Fremont, CA), with known rabbit cross-reactiv-
ity, as a primary antibody. Then an avidin-biotin com-
plex (Lab Vision Corp) was incubated to label the
primary antibody, and a color reagent was added at the
end to allow the horseradish peroxidase reaction to take
place.
Analysis of VEGF expression
Using the image capturing software Image Pro Plus
4.1 for Windows (Media Cybernetics, Carlsbad, CA), 6
random fields from each section were captured at 40
magnification using an RT Color digital camera (Diag-
nostic Instruments Inc, Sterling Heights, MI). A total of
3 sections were used for each defect resulting in a total
of 18 random images for each right and 18 of each left
defect. The area stained for VEGF in each field was
measured by setting a threshold intensity above which
a pixel is counted using the Image Pro Plus software.
To determine whether there was any difference in
VEGF expression in the center of the defects compared
to the margins of the defects, 2 images were taken from
the central one third of the defect and 4 images were
taken from the margins and their VEGF staining mea-
sured.
Statistical analysis
One-way analysis of variance (ANOVA) was em-
ployed for analysis within and between the groups.
When differences were found, the Student-Newman-
Keuls method was used as a post hoc test to determine
which groups were significantly different.
Comparisons of VEGF staining between the
15-mm and 18-mm defects in the same rabbits, and
between the margins and central regions within each
defect, were made using the paired t test. Statistical
significance was set at P  .05. All statistical anal-
yses were performed using Sigma Stat software
(v3.0, SYSTAT, San Jose, CA).
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Gross appearance and histological evaluation
As reported previously, gross analysis of the post-
mortem defect size showed the defects of the HBO-
treated groups to be smaller than those of the NBO
groups with complete union at 12 weeks in all subjects
of the HBO therapy group. Histological analysis re-
vealed that healing of the defects in the NBO group was
mainly by scar formation with only a few bony islands
scattered along the defect margins. By comparison, the
defects from the HBO-treated animals contained sig-
nificant amounts of bone and marrow that completely
bridged the defects by 12 weeks. The bone in the
6-week HBO defects was predominantly woven, but by
12 weeks it tended to be more lamellar in nature (Fig.
1, A-D).
VEGF staining
VEGF expression in all groups occurred throughout
the fibrous tissue and marrow, with more intense stain-
ing often seen near bone. When the extent of VEGF
staining was compared between the 15-mm and 18-mm
defects, no differences were detected in any group
(Table I) or when considering all the samples as a
whole. Consequently, the results for the 2 defects in
each animal were averaged to provide 1 result per
animal for further analysis. The means and standard
deviations for the area stained by VEGF for each group
are reported in Table II and displayed in Fig. 2.
Fig. 1. Histological appearance of HBO and NBO defects at
new bone is seen within the defect. B, NBO 6-weeks group. A
in the group treated with HBO. C, HBO 12-weeks group. Th
The defects were filled predominantly with dense fibrous tis
margin of original defect. (Hematoxylin-eosin stain; magnifiComparison of the areas stained for VEGF betweenthe HBO and NBO groups 6 weeks postsurgery showed
that there was a significantly greater area staining for
VEGF in the samples from HBO-treated rabbits (P 
.012) (Figs. 3 and 4).
Comparison of VEGF staining between the animals
killed at 6 and 12 weeks postsurgery showed that there
was no difference between the 2 NBO groups; how-
ever, there was a significant decline in VEGF staining
between the 6- and 12-week HBO samples (P  .008).
The 12-week HBO and NBO samples had similar
amounts of VEGF staining (Fig. 5).
We also investigated whether there was any detect-
able difference in the amount of VEGF staining be-
12 weeks. A, HBO 6-weeks group. A significant amount of
gh new bone is present within the defect, it is much less than
e defect is bridged with new bone. D, NBO 12-weeks group.
, connective tissue; MB, mature bone; NB, new bone; OD,
4.)
Table I. Comparison of VEGF staining between 15-
and 18-mm defects
15 mm 18 mm P(15 mm vs 18 mm)
HBO, 6 weeks 413  171 571  474 .430
NBO, 6 weeks 222  112 250  137 .141
HBO, 12 weeks 167  140 104  40 .371
NBO, 12 weeks 163  71 145  47 .651
All values are group means SD of the subject means of stained area
(m2) within a field of view. Each subject mean represented the
average of 6 fields per slide, 3 slides per defect. Each rabbit had one
15-mm and one 18-mm defect.
P values were calculated using the paired t test.
HBO, hyperbaric oxygen; NBO, normobaric oxygen; VEGF, vascular
endothelial growth factor.6 and
lthou
e entir
sue. CTtween the center and margins of the defect in the
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tected (Table III).
DISCUSSION
HBO has been shown to enhance bone repair in
critical-sized calvarial defects6; however, the mecha-
nism by which this occurs has not been elucidated.
It has been reported that HBO can increase neovas-
cularization in soft tissue wounds16 and the in-growth
of new blood vessels into the defect is an essential step
in bone repair.11 VEGF and basic fibroblast growth
factor (FGF) have been identified as the primary growth
factors implicated in neovascularization (angiogenesis)
in vitro.12 However, in vivo, the role of FGF in angio-
Table II. Comparison of VEGF staining between HBO
and NBO groups
6 wk 12 wk P(6 wk vs 12 wk)
HBO 520  287 147  38 .008
NBO 240  121 149  76 .630
P(HBO vs NBO) .012 .987
All values are group means SD of the subject means of stained area
(m2) within a field of view. Each subject mean represented the
average of 6 fields per slide, 3 slides per defect, 2 defects per subject
(36 fields measured per subject).
Results of the 15- and 18-mm defects were combined in this analysis.
P values were determined using the Student-Newman-Keuls post hoc
test following analysis of variance.
HBO, hyperbaric oxygen; NBO, normobaric oxygen; VEGF, vascular
endothelial growth factor.
Fig. 2. VEGF-stained HBO-treated defects at 6 weeks. Rab-
bits had been exposed to HBO therapy (90 minutes at 2.4
atmospheres with 100% oxygen) 5 days a week for 4 weeks.
Cells stained for VEGF were seen throughout the defect,
however the most intense VEGF staining was seen near areas
of bone. (Magnification 200.)genesis has been questioned. Nissen and coworkers17demonstrated that while FGF levels dramatically rise
immediately after injury, they also return to normal
within 3 days, several days prior to the onset of angio-
genesis. Conversely, VEGF increased, peaking at 7
days postinjury, matching the initiation of angiogenic
activity that began after 1 week.18 A similar time course
for VEGF expression has been reported for fracture
healing.19
The current study was unable to address the effect of
HBO on VEGF expression prior to 6 weeks, as this was
a retrospective study. VEGF expression following
trauma in soft tissue and bone has been reported to
Fig. 3. VEGF-stained untreated defects at 6 weeks. Only low
levels of VEGF staining were seen throughout the defect.
Very few cells were seen that stained strongly. (Magnification
200.)
Fig. 4. VEGF-stained HBO-treated defects at 12 weeks. Lim-
ited VEGF staining was observed, even near areas of bone.
(Magnification 200.)return to normal within 21 days following trauma.17,19
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the NBO-treated animals had been elevated following
trauma, they had returned to background levels before
6 weeks, explaining the similarity in levels observed
between the 6-week and 12-week defects in the NBO
group.
Nevertheless, we were able to demonstrate that
VEGF levels were elevated 6-weeks following trauma
when the rabbits had been exposed to HBO. It has been
shown in a rabbit ischemic ear model that HBO therapy
(100% O2; 2.0 ATA (atmospheres absolute); 90 min-
utes a day for 14 days) transiently increased tissue
oxygen partial pressure in the ischemic tissue from
hypoxic levels to significantly above values seen in
NBO nonischemic tissue. However O2 partial pressure
returned to ischemic values within 4 hours.20 It is
possible in our study that the cycling between hyper-
Fig. 5. VEGF-stained untreated defects at 12 weeks. VEGF
staining in the untreated defects is similar to that in the HBO
defects. (Magnification 200.)
Table III. Comparison of VEGF staining between the
center and margins of the defects
Center Margin P(center vs margin)
HBO, 6 weeks 633 462 464 246 .255
NBO, 6 weeks 181 200 269 188 .105
All values are group means SD of the subject means of stained area
(m2) within a field of view.
Two random fields were measured from the central one third of each
section and 4 random fields were measured from the margins of the
same defect. Three sections were measured per defect.
Results of the 15- and 18-mm defects were considered separately in
this analysis.
P values were calculated using the paired t test.
HBO, hyperbaric oxygen; NBO, normobaric oxygen; VEGF, vascular
endothelial growth factor.baric and hypoxic conditions caused by the repeated90-minute treatments of 2.4 atmosphere hyperbaric ox-
ygen exposes the cells of the wound to a normoxic or
hyperoxic environment at the injured site, removing the
hypoxic stimuli for VEGF synthesis. However, upon
return to normal atmosphere the defects reexperienced
a hypoxic environment. This change from normoxic to
hypoxic conditions may have resulted in the continued
and prolonged synthesis of VEGF beyond what would
occur in healing under NBO conditions. While this
theory must be tested, there are examples where the
same stimuli can alter gene expression and tissue for-
mation depending on whether it was applied in a con-
stant or cyclic manner. Examples include differences
between constant and cyclic hydrostatic pressure21 and
cyclic and chronic administration of parathyroid hor-
mone (PTH).22
Sheikh et al.,23 using a different HBO protocol
(100% O2; 2.1 ATA; 90 minutes, twice per day for
7days), demonstrated elevated VEGF levels in a sub-
cutaneous wound cylinder mouse model following 7
days of HBO. However, in contrast to our results, they
reported that VEGF levels returned to baseline within 3
days of termination of treatment. This may have been
due to the differences in the HBO protocol, duration of
treatment, and tissue and/or species studied.
Another interesting finding was that there was no
difference in VEGF expression between the 2 different
defect sizes under either of the treatment conditions. It
is possible that in the NBO group differences may have
been observed if we had been able to look at earlier
stages of healing, prior to VEGF returning to basal
levels. In the case of the HBO treatments, time of
observation may also have been a factor. However, it is
also possible that as complete union of both the 15- and
18-mm defects did occur at 12 weeks, the HBO therapy
was able to induce VEGF expression evenly across the
whole defect.
As this study was a retrospective study using ar-
chived tissue samples, the study was not optimized for
quantifying the VEGF expression. Specific shortcom-
ings in the study design include that the sample prep-
aration was not optimized for immunohistochemical
analysis, as samples were fixed in 10% neutral formalin
and demineralized using formic acid. Second, the time
points studied, while useful for studying defect repair,
did not permit us to investigate the levels of VEGF
earlier at periods previously seen to have elevated
VEGF during normoxic healing and when angiogenesis
would have been initiated. Third, VEGF exists as mul-
tiple isoforms, and there is differential expression of
these isoforms during healing.24 The antibody used in
this study was raised against one of the most common
isoforms, VEGF121, however we do not know it’s
cross-reactivity with the other isoforms.
OOOOE
422 Fok et al. April 2008In conclusion, this retrospective study did demon-
strate differences in VEGF expression between HBO
and NBO and is the first study we are aware of to report
such differences during bone repair, or over such an
extended period in any tissues.
This study was generously funded by grants from
Straumann Canada and the Toronto Academy of
Dentistry.
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Objectives. This study was undertaken to evaluate the effect of hyperbaric oxygen (HBO) on the repair of critical-sized
defects in the presence and absence of a nonvascularized autogenous bone graft.
Study design. Ten New Zealand White rabbits were randomly divided into 2 groups of 5 animals each. Bilateral 15-mm
calvarial defects were created in the parietal bones of each animal, resulting in 20 critical-sized defects. Autogenous bone grafts
(ABG) were allocated to the left or right defect of each animal. Group 1 received HBO treatment at 2.4 ATA 100% oxygen for 90
minutes per day 5 days a week for 4 weeks. Group 2 served as a normobaric (NBO) control, breathing only room air. The
animals in each group were humanely killed at 6 weeks. Calvaria were analyzed by micro-CT and histomorphometry.
Results. Micro-CT analysis indicated that as expected there was a higher bone mineral density (BMD) and bone mineral
content (BMC) in ABG than unfilled defects (P  .05). However, there was a significant decline in the bone mineral content
(BMC) of HBO-treated grafted defects compared to NBO-treated grafted defects (P  .05). Histologically complete bridging
of the defect was observed in both NBO and HBO ABG grafted defects. Histomorphometic analysis showed that HBO
treatment increased new bone and marrow, and reduced fibrous tissue in the defects (P  .01 for all). Examination of
residual graft showed a near significant reduction in residual graft volume (11.2  4.7 versus 19.1  7.7, HBO versus NBO
P  .085) in the HBO group. The use of a graft increased new bone and marrow in the NBO group (P  .001 for both);
however, in the HBO-treated animals the differences between grafted and ungrafted were not significant.
Conclusion. HBO enhances bony healing in ungrafted rabbit calvarial critical-sized defects and may increase the rate of residual
graft resorption in autogenous bone–grafted defects. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;107:157-163)aProfessor and Head of Oral and Maxillofacial Surgery, University of
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lagen synthesis, and granulation tissue formation.1 Hy-
perbaric oxygen (HBO) therapy is the exposure of the
patient to 100% oxygen at elevated pressure. HBO has
been used to improve the healing of a variety of com-
promised or hypoxic wounds including diabetic ulcers,
radiation-induced tissue damage, gangrene, and necro-
tizing anaerobic bacterial infections.2,3
HBO therapy is thought to increase wound healing
by increasing the amount of oxygen dissolved in the
blood (oxygen tension), which in turn can increase the
amount of oxygen delivered to the hypoxic wound
site.4 HBO can promote angiogenesis5 and results in an
increase in the vessel density in irradiated tissue.6
The current standard of practice for the treatment of
critical-sized defects is the use of autogenous bone
grafts. While for small defects the graft can be obtained
intraorally,7 larger defects require the harvesting of
bone extraorally, which requires a second surgical site
and results in increased risk of complications.
Studies have demonstrated that HBO increases bone
formation in bone harvest chambers in rabbits8 and
elevates alkaline phosphatase activity, a marker of bone
formation, in rats following mandibular osteotomy9 and
increased osteoblastic activity and angiogenesis in ir-
radiated mandibles undergoing distraction.10
To our knowledge, only one study has investigated
the ability of HBO to promote bony healing of critical-
sized defects. This study demonstrated that HBO en-
abled the healing of critical- and supra critical–sized
calvarial defects in rabbits,11 possibly due to the en-
hanced expression of vascular endothelial growth factor
(VEGF).12 These results suggest that HBO may mini-
mize the amount of graft required to achieve adequate
bone healing of such defects.
The aim of the current study was to determine
whether the use of HBO in the absence of a graft
produces critical-sized defect healing equivalent to that
caused by a graft and whether HBO enhances healing
of defects that do contain autogenous bone grafts.
MATERIALS AND METHODS
Surgical protocol
Ten adult, skeletally mature, male New Zealand
White rabbits weighing 3 to 4 kg were randomly di-
vided into 2 groups of 5 animals. The animals of Group
1 (HBO) underwent HBO treatment using a protocol
described in a previous study.11 Rabbits were placed in
a hyperbaric chamber and exposed to 100% oxygen at
2.4 atmospheres absolute for 90 minutes per day for 5
days a week for 4 week (20 days total). The animals of
Group 2 served as normobaric controls (NBO) and
were left to heal at room air without any further inter-
vention.Before the HBO treatment sessions, bilateral 15-mm
full-thickness osseous defects were created surgically
in the parietal bones of all the animals. The surgical
procedure was performed in sterile fashion in accor-
dance with the University of Toronto animal research
committee protocol number 20005155. Autogenous
bone grafts (ABG) were placed randomly on the right
or left side of each animal (Fig. 1). The other defect was
left unfilled. HBO treatment was initiated 24 hours after
surgery.
Rabbits were humanely killed 6 weeks postoperatively.
The parietal bones were harvested using an oscillating saw
preserving the pericranium over the defects. Care was also
taken to preserve the sagittal, coronal, and the lambdoid
sutures because they served as a reference to the circum-
ference of defects. The final harvested specimens mea-
sured 30  25  12 mm in the greatest dimensions.
Specimens were fixed in 10% formalin prior to analysis
by micro-computed tomography (micro-CT).
Micro-computed tomography
This study used an Explore Locus SP micro-CT
scanner (GE Medical Systems, London, Ontario, Can-
ada). Prior to scanning the specimens a calibration scan
was performed using a synthetic bone, a water, and an
air sample.
Calvarial specimens were scanned using the fast
Fig. 1. Unfilled defect from rabbits under normobaric condi-
tions. These defects were mostly filled with fibrous tissue,
with the occasional areas of bone formation and very little
marrow (hematoxylin and eosin [H&E], original magnifica-
tion 20).mode using 0.05-mm sections. Each specimen took 120
OOOOE
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images (Fig. 2) was done using Microview software
(GE Medical Systems) after calibrating using the bone,
water, and air standard values. The reconstructed 3-de-
mensional (3D) image was then traced in 3 dimensions
to the circumference of the original defect margins.
This allowed the creation of a 3D reconstruction of the
defect, which was referred to as the region of interest
(ROI) (Fig. 3). A threshold level was selected manually
based on 25% of the bone standard provided by the
manufacturer.
The ROI of each specimen was analyzed for total
volume (TV), bone volume (BV), the bone volume
fraction (BVF  BV/TV), bone mineral content
(BMC), and bone mineral density (BMD). The software
also permitted us to measure the mineral content and
mineral density of the voxels, which are counted as
“bone” based on the threshold setting selected. These
measures are called the tissue mineral content (TMC)
and tissue mineral density (TMD).
Histomorphometry
Upon completion of micro-CT scanning, specimens
were decalcified using 45% formic acid and 20% so-
dium citrate for 4 weeks. Each bone was sectioned into
Fig. 2. Autogenous bone–grafted defects under normobaric
conditions.Trabeculae of new bone formed around and some-
times incorporated the residual autogenous bone graft (ABG).
The ABG could be clearly distinguished from the new bone
due to the empty osteocyte lacunae. Extensive marrow is
present throughout the defect (H&E, original magnification
20).2 portions: an anterior and posterior portion. Both por-tions were embedded in paraffin and 7-m sections
were prepared and stained with hematoxylin and eosin.
Sections in the middle of the defects, representing the
greatest dimension, were examined under the light mi-
croscope. Ten randomized sections within the middle
of defects were digitized using a digital camera (RT
Color; Diagnostic Instruments Inc., Sterling Heights,
MI). A blinded investigator traced the images for new
bone formation.
Statistical analysis
All data were tested for normality and equal vari-
ance. Results were compared across all groups using 1-
and 2-way analysis of variance (ANOVA) with Student
Newman Keuls (SNK) post hoc testing for normal data
of equal variance or Holm-Sidak post hoc testing for
non-normal/non-equal variance data. Paired t tests were
used to compare the defects within the animals. As
there was only graft in 2 groups, a t test was used to
compare the amount of residual graft between the HBO
and NBO defects that had been grafted with ABG. All
statistical analyses were performed using SigmaStat
v3.5 (Systat Software, San Jose, CA). Statistical signif-
icance was considered to be P less than .05.
RESULTS
Histological analysis
The unfilled non-HBO defects were predominantly
Fig. 3. Unfilled defect exposed to hyperbaric oxygen condi-
tions. Thick blocks of new bone are surrounded by dense
fibrous tissue. Only small amounts of marrow are seen, within
the new bone (H&E, original magnification 20).filled with fibrous tissue that contained an occasional
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defect margins, although small islands of woven bone
were occasionally seen in the fibrous tissue more cen-
trally (Fig. 1).
The ABG non-HBO defects were completely bridged
with bony tissue. The defects were filled with a mixture
of nonvital cortical bone from the graft, newly formed
bone, and vascular marrow (Fig. 2).
It was difficult to distinguish the defect margin in the
unfilled HBO-treated defects. The defects were com-
pletely bridged with new bone, which tended to thin
toward the center of the defects, with the dural and
periosteal edges being composed of denser fibrous tis-
sue. The new bone contained marrow elements (Fig. 3),
which were not as extensive as in the grafted defects.
Similar to the HBO void defects the margin of the
defect was difficult to identify in the ABG-grafted
HBO-treated defects. These defects were completely
bridged with extensive amounts of new bone and mar-
row. Devitalized remnants of the graft were still visible
(Fig. 4).
Micro-computed tomography
Statistical analysis of the micro-CT results indicated
that the presence of the graft resulted in increased BV,
BMC, BMD, and BVF compared to unfilled defects
under both NBO and HBO (P  .05) (Fig. 5). Com-
Fig. 4. Autogenous bone–grafted defects under hyperbaric
oxygen conditions. New bone forms along with and merges
into the residual graft matrix. The remaining space is filled
with marrow. No fibrous tissue is visible (H&E, original
magnification 20).parisons between the HBO and NBO autogenous bone–grafted defects revealed that the HBO-grafted defects
had significantly lower BV (P  .03) and BMC (P 
.05), although the reductions in BVF and BMD did not
reach significance (P  .123 and .078, respectively).
No significant differences between the HBO and NBO
unfilled defects were seen in any of the parameters
measured (Table I).
Histomorphometry
Histological analysis (Table II) demonstrated that
HBO-treated unfilled defects had significantly more
new bone (P  .001) and marrow (P  .05) and less
Fig. 5. Micro-CT results. Bone mineral content (BMC) (A)
and bone volume fraction (BVF) (B).The defects containing
autogenous bone grafts have significantly higher BMC and
BVF than the ungrafted defects (P  .05). Comparisons
between the HBO and NBO autogenous bone–grafted defects
revealed that the HBO-grafted defects had significantly lower
BMC (P .05), although the reductions in BVF did not reach
significance (P  .123). No significant differences between
the HBO and NBO unfilled defects were seen in either of
these parameters. Data are plotted as mean  SD.fibrous tissue (P  .05) than unfilled defects exposed
Ranks.
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togenous bone showed no statistical differences in
any of the parameters measured, although the lesser
amount of residual graft present in the HBO com-
pared to NBO defects neared significance (P  .085)
(Fig. 7).
As expected in the normobaric defects there was
significantly more new bone and marrow and less fi-
brous tissue in the grafted defects (P  .05). However,
comparing the unfilled and autogenous bone–grafted
defects in the HBO-treated animals there was no sig-
nificant difference in the amount of new bone (P 
.196), although there was less marrow and more fibrous
tissue in the unfilled defects (P  .05).
DISCUSSION
The current “gold standard” for the treatment of
bony defects that are unable to heal spontaneously
(critical-sized defects) is the use of autogenous bone
grafts. However, the volume of bone available for
grafting is limited and the use of large grafts results
in significant complications including donor site
morbidity, loss of blood, and extended time in sur-
Table I. Micro-CT analysis
NBO
Unfilled ABG
TV(mm3) 233  37 263  55
BV(mm3) 41  7 140  22
BVF (%) 17.6  2.1 53.9  6.4
BMC (mg) 31.2  6.3 118.0  21.3
BMD (mg/mm3) 134  20 451  25
TMC 25.6  4.5 90.3  13.5
TMD 627  27 645  20
NBO, normobaric oxygen; HBO, hyperbaric oxygen; ABG, autogen
volume; BVF, bone volume fraction; BMC, bone mineral content; BM
density.
*Equal variance test failed – P calculated using 1-way ANOVA on
Table II. Histomorphometric analysis
NBO
Type of tissue (%) Unfilled ABG
New Bone 19.7  2.6 36.6  8.6
Marrow 6.3  3.6 37.8  9.1
Bone  Marrow 26.0  2.7 74.4  8.1
Fibrous 74.0  2.7 6.4  1.8
Graft N/A 19.1  7.7
NBO, normobaric oxygen; HBO, hyperbaric oxygen; ABG, autogen
*Data not normal P value generated by 1-way ANOVA on Ranks.
†Data not equal variance, P value generated by 1-way ANOVA on
‡P value for residual graft was determined by t test.gery. HBO therapy has been shown to promote thehealing of unfilled critical-size defects in rabbits, and
may be useful as a replacement for autogenous grafts
in certain instances and as an adjunct therapy to
autogenous bone grafting, minimizing the amount of
graft required in others. The aim of this study was to
evaluate the effect of HBO on the healing of critical-
sized defects in the presence and absence of autog-
enous bone grafts in comparison to defect healing
with grafts under normobaric conditions.
The current study demonstrated that histologically
there was significantly more bone (P  .001) and
marrow (P  .05) in the HBO-treated unfilled defect
than the control unfilled defects in untreated animals.
These results agree with the only other previous study
to investigate the effect of HBO on critical-size defect
healing.11 Interestingly, we were unable to demonstrate
this difference by micro-CT, suggesting that the newly
formed bone had not yet matured and become fully
mineralized.
Comparison of the amounts of new bone in the
HBO-treated unfilled defect and the normobaric au-
tografted defect indicated more bone in the HBO group
that neared significance (46.7  5.3 versus 36.6  8.6;
HBO 1-way ANOVA
Unfilled ABG Pbetween groups
191  27 189  66 .076
39  17 87  36 .001
20.0  7.3 46.2  11.0 .001
32.4  13.0 76.0  27.6 .002*
167  53 403  52 .001
23.8  11.3 53.9  24.1 .001
602  26 612  32 .096
e graft; ANOVA, analysis of variance; TV, total volume; BV, bone
e mineral density; TMC, tissue mineral content; TMD, tissue mineral
HBO 1-way ANOVA
Unfilled ABG Pbetween groups
46.7  5.3 41.4  6.9 .001
26.7  9.0 38.7  5.7 .004*
73.5  12.5 80.1  5.5 .008†
26.5  12.5 8.8  6.1 .001†
N/A 11.2  4.7 .085‡
e graft; ANOVA, analysis of variance.ous bon
D, bonous bon
Ranks.P  .054). Conversely, there was significantly less
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defect than the NBO-grafted defect (marrow: 26.7  9.0
versus 37.8 9.1; P .05; fibrous 26.5 12.5 versus 6.4
 1.8; P  .05). When the amount of bone and marrow
are considered as a single measure of “reparative tissue”
the amounts in the HBO unfilled and NBO-grafted defects
were almost identical (73.5  12.5 versus 74.4  8.1),
with the a volume equivalent to that occupied by residual
graft in the NBO defects being occupied by fibrous tissue
in the HBO-treated defects.
Histomorphometric comparison of the HBO and
Fig. 6. Histomorphometry results. A, Amount of new bone.
B, The amount of marrow.HBO-treated unfilled defects had
significantly more new bone (P  .001) and marrow (P  .05)
than unfilled defects exposed to normobaric air. Comparing the
unfilled and autogenous bone–grafted defects in the HBO-
treated animals there was no significant difference in the amount
of new bone (P  .196), although there was less marrow in the
unfilled defects (P  .05). Data are plotted as mean  SD.NBO defects that contained autogenous grafts revealedthere were no significant differences, although the re-
duction in the amount of residual graft in the HBO
group neared significance (11.2  4.7 versus 19.1 
7.7; P  .085). However, the micro-CT did show that
there was a significant reduction in the bone mineral
content of the defect (P  .05) and a near significant
reduction in bone mineral density (P  .078). The
difference between the micro-CT and histomorphomet-
ric results may indicate that there is increased resorp-
tion and/or demineralization of the residual graft, which
would not as easily be detected by histomorphometry.
Sawai et al.13 investigated the effect of HBO on
mandibular defect healing with autogenous bone grafts
in rabbits by histology. They reported that HBO in-
creased the amount of bone formed initially and that the
graft becomes incorporated into the surrounding bone
making it difficult to distinguish the graft from new
bone after 4 weeks, although they did not evaluate the
effects quantitatively. Chen et al.14 demonstrated that
HBO increased the rate of union of rabbit spinal fusions
in the presence of autogenous grafts.
In conclusion, HBO enhances bony healing in non-
grafted rabbit calvarial critical-sized defects with a
bone volume that is comparable with autogenous non-
vascularized bone grafting. HBO resulted in a reduction
of the bone mineral content of the autogenous bone–
grafted sites. Angiogenesis within the graft may ac-
count for the reduction in BMD observed during the
experimental period of this study.
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Objectives. The aim of this study was to assess the possible effect of hyperbaric oxygen (HBO) on the healing of critical-
sized defects that were grafted with demineralized bone matrix (DBM) combined with Pluronic F127 (F127) to form a gel or
putty, or a commercially available biphasic calcium phosphate (BCP), mixed either with blood or F127 to form a putty.
Study design. Twenty New Zealand White rabbits were randomly divided into 2 groups of 10 animals each. Bilateral
15-mm calvarial defects were created in the parietal bones of each animal, resulting in 40 critical-sized defects. Group
I defects were grafted with either DBM putty or DBM gel. Group II defects were grafted with either BCP or BCP putty.
Five animals from each group received HBO treatment (100% oxygen, at 2.4 ATA) for 90 minutes per day 5 days a
week for 4 weeks. The other 5 animals in each group served as a normobaric (NBO) controls, breathing only room air.
All animals were humanely killed at 6 weeks. The calvariae were removed and analyzed by micro computed
tomography (mCT) and histomorphometry.
Results. mCT analysis indicated a higher bone mineral content (BMC, P  .05), bone volume fraction (BVF; P  .001), and
bone mineral density (BMD; P  .001) of the defects grafted with BCP rather than DBM. Furthermore, the voxels that were
counted as bone had a higher tissue mineral density (TMD) in the BCP- than in the DBM-filled defects (P  .001).
Histologically complete bony union over the defects was observed in all specimens. Histomorphometric analysis
showed that DBM-filled defects had more new bone (P  .007) and marrow (P  .001), and reduced fibrous tissue
compared with the BCP defects (P  .001) under NBO conditions.
HBO treatment reduced the amount of fibrous tissue in BCP filled defects (P  .05), approaching levels similar to that in
matching DBM-filled defects. HBO also resulted in a small but significant increase in new bone in DBM-grafted
defects (P  .05).
Conclusion. Use of DBM or BCP promoted healing in these critical-sized defects. Hyperbaric oxygen therapy resulted
in a slight increase in new bone in DBM-grafted defects and much larger reduction in fibrous tissue and matching
increases in marrow in BCP-grafted defects, possibly through increased promotion of angiogenesis. (Oral Surg Oral
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healing of bony defects that will not heal spontaneously
(critical-sized defects).5 The mechanism by which
HBO is believed to work is that it increases the amount
of oxygen dissolved in the blood (oxygen tension),
which in turn can increase the amount of oxygen de-
livered to the hypoxic wound site, stimulating angio-
genesis and osteogenesis.6,7
The current standard for the treatment of critical-
sized defects is the use of autogenous bone grafts8;
however, studies have shown that bone graft substitutes
can be used to promote bony regeneration in critical-
sized defects.9 Demineralized bone matrix (DBM) has
been shown to induce bony in-growth to critical-sized
defects; however, this material lacks rigidity because of
lack of mineralized components in its matrix. Alterna-
tively, ceramics such as hydroxyapatite have been
shown to have good rigidity but they take longer to
resorb and be replaced by bone. Ceramics also have a
tendency to integrate by fibrous union. HBO has been
demonstrated to reduce bone mineral density (BMD) in
particulate autogenous bone grafts possibly by activat-
ing angiogenesis and resorption of the grafted ma-
trix.10,11 These results suggest that HBO may promote
resorption and minimize fibrous union when ceramics
are used.
The aim of this study was to determine if the use of
HBO in combination with DBM or bone ceramic en-
hances osseous healing and whether HBO prevents
fibrous union when bone ceramics are used.
MATERIALS AND METHODS
The surgical protocol for this study was approved by
the University of Toronto Animal Care and Ethics
Committee (Protocol number 20005145). The surgical
technique, anesthetics, and prophylactic antibiotics were
described in a previous publication.6 In brief, bilateral
15-mm full thickness osseous defects were created surgi-
cally in the parietal bones of 20 adult, skeletally mature,
male New Zealand White rabbits weighing 3 to 4 kg.
Bone graft substitutes were placed randomly on the right
or left side of each animal. Animals were randomly di-
vided into 2 groups of 10 subjects.
Experimental design
Group I (DBM) n  10. Allogeneic demineralized
bone matrix was prepared from rabbit long bones by
treatment with 0.6 M HCl for 48 hours followed by
extensive washing and lyophilization.
Pluronic F-127 (F127; poloxamer 407, BASF Can-
ada Inc., Toronto, Canada) was prepared by slowly
adding 33g F127 to 100 mL MilliQ water held at 4°C.
The F127 was then autoclaved for sterility.Animals of Group 1 were grafted with either DBM
putty or DBM gel, both of which were prepared with
allogeneic rabbits’ long bones. DBM putty was prepared
as a mixture of 70% DBM and 30% Pluronic F-127 gel.
DBM gel was prepared as a mixture of 40% DBM and
60% Pluronic F-127 gel. The main differences between
the gel and the putty are the consistency of the mixture
and the amount of DBM in the compound.
Group II (BCP) n  10. Animals of Group II were
grafted with either BCP or BCP putty. Biphasic cal-
cium phosphate (Straumann AG, Basel, Switzerland) is
a commercially available synthetic bone substitute. It is
made of a mixture of 60% hydroxyapatite and 40%
tricalcium phosphate. BCP putty was prepared as a
mixture of 70% BCP with 30% Pluronic F-127 gel. In
defects where BCP was used without the gel, it was
mixed with the animal’s own blood.
Hyperbaric oxygen therapy. Five animals from each
group underwent HBO. Rabbits were placed in a hy-
perbaric chamber and exposed to 100% oxygen at 2.4
atmospheres absolute for 90 minutes per day for 5 days
a week for 4 weeks (20 treatments total). Five animals
in each group served as normobaric controls (NBO) and
were left to heal at room air without any further inter-
vention. HBO treatment was initiated 24 hours after
surgery.
Rabbits were humanely killed 6 weeks postopera-
tively. The parietal bones were harvested using an
oscillating saw. Care was also taken to preserve the
pericranium, the sagittal, coronal, and the lambdoid
sutures because they served as a reference to the cir-
cumference of the defects. The final harvested speci-
mens measured 30  25  12 mm in the greatest
dimensions. Specimens were fixed in 10% formalin
before analysis by micro computed tomography (mCT).
Micro-computed tomography
This study used an Explore Locus SP micro CT
scanner (GE medical systems, London, Ontario, Can-
ada). Before scanning the specimens, a calibration scan
was performed using the manufacturers’ standard, which
includes synthetic bone, water, and an air sample.
Calvarial specimens were scanned at a resolution of
28 m. Reconstruction of scanned images was done
using the manufacturer’s software after calibration us-
ing the bone, water, and air standard values. The re-
constructed 3-dimensional image was then analyzed
using MicroView software (v2.1.2 GE Medical Sys-
tems, London, Ontario, Canada). Before analysis,
threshold values must be determined that permit the
software to distinguish bone and ceramic from soft
tissue. A lower threshold was selected that would count
bone  ceramic by identifying areas of bone within the
defects tracing regions of interest that incorporated only
g analy
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(BVF) at a range of threshold values. The “bone 
ceramic” threshold was determined to be the highest
threshold value that gave a BVF greater than 0.95 for
all bone ROIs (regions of interest).
The threshold value for the “ceramic only” was de-
termined in a similar manner by tracing 8 particles in
each defect that could be clearly identified. The highest
threshold that resulted in every particle having a BVF
(which in this case is the ceramic volume fraction) was
greater than 0.95.
After determination of the threshold values, the mar-
gins of the defect were traced in 3 dimensions resulting
in an ROI that incorporated the entire defect.
The ROI of each specimen was analyzed for total
volume (TV), bone volume (BV), bone volume fraction
(BVF  BV/TV), bone mineral content (BMC), and
bone mineral density (BMD). The software also per-
mitted measurement of the mineral content and mineral
density of the voxels. which are counted as “bone”
based on the threshold setting selected. These measures
are called the tissue mineral content (TMC) and tissue
mineral density (TMD). The measurements were made
at both the bone  ceramic and ceramic only threshold
values.
To correct for the presence of BCP in the defects
corrected values for BV, BMC, BMD, TMC, TMD,
and BVF were determined by subtracting the values
obtained at the ceramic only threshold from those for
the bone  ceramic threshold and recalculating.
Histomorphometry
Upon completion of mCT scanning, specimens were
decalcified using 45% formic acid and 20% sodium
citrate for 4 weeks. Each bone was sectioned into 2
Table I. MicroCT analysis
DBM
GEL PUTTY
NBO HBO NBO H
Vol (mm3) 186  103 161  42 177  95 179
BV (mm3) 67  36 62  8 64  36 65
BVF (%) 35  7 40  7 37  8 34
BMC (mg) 46  23 38  7 41  22 41
TMC (mg) 29  16 25  4 27  16 26
BMD (mg/mL) 223  34 244  28 232  36 233
TMD (mg/mL) 416  30 410  20 410  4 401
DBM, demineralized bone matrix; BCP, biphasic calcium phosphate
60% F127 (vol/vol); PUTTY, the DBM or BCP granules were mixe
oxygen; HBO, hyperbaric oxygen; BV, bone volume; BVF, bone volum
bone mineral density; TMD, tissue mineral density.
*Data were not normally distributed and groups were compared usinportions: an anterior and posterior portion. Both por-tions were embedded in paraffin and 7-m sections
were prepared and stained with hematoxylin and eosin.
Sections in the middle of the defects, representing the
greatest cross-sectional dimension, were examined un-
der the light microscope. Ten randomized sections
within the middle of defects were digitized using a
digital camera (RT Color; Diagnostic Instruments Inc.,
Sterling Heights, MI). A blinded investigator analyzed
each section for the amount of new bone, marrow,
fibrous tissue, and residual graft using Image ProPlus
software (Media Cybernectics, Bethesda, MD).
Statistical analysis
Results were tested for normality and equal variance.
Each parameter was compared across all groups using
1-way Analysis of Variance (ANOVA) for normal data
and Kruskal-Wallis 1-way ANOVA on RANKS for
non-normal data, followed by Student-Newman-Keuls
(SNK) post hoc testing. Statistical significance was
considered to be P less than .05. All analyses were done
using Sigma Stat v3.5 (Systat Software, San Jose, CA).
RESULTS
Micro-computed tomography
All parameters were examined for significant differ-
ences between the different groups using ANOVA (Ta-
ble I). Four different experimental conditions were
compared in this study: BCP versus DBM, HBO versus
NBO, and 2 different formulation comparisons of blood
versus F127 putty within the BCP group and F127 gel
versus F127 putty within the DBM group. Following a
significant ANOVA result, the matched pairs that were
exposed to these experimental conditions were tested
for significant differences using a post hoc test (ie, for
comparisons of BCP and DBM, the NBO-BCP-putty
BCP
Blood PUTTY ANOVA
NBO HBO NBO HBO P
162  56 180  30 143  14 128  28 .096
103  33 111  29 91  9 72  21 .017
64  4 61  6 64  3 56  8 .001
110  36 116  27 84  7 66  19 .001*
107  35 113  29 80  7 61  19 .001*
682  43 641  81 594  52 512  72 .001
563  23 547  21 530  23 506  10 .001
the DBM granules were mixed with Pluronic F127 at 40% DBM to
F127 at 70% DBM/BCP to 30% F127 (vol/vol); NBO, normobaric
ion; BMC, bone mineral content; TMC, tissue mineral content; BMD,
sis of variance (ANOVA) on Ranks.BO
 18
 10
 7
 5
 5
 27
 11
; GEL,
d with
e fractwas compared with the NBO-DBM-putty and the
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putty) (Table II).
ANOVA of the mCT results demonstrated signifi-
cant differences between the groups for all parameters
except total volume (see Table I). Identification of the
groups that had significantly different bone volumes
(BV) required use of the Fisher least significant differ-
ences (LSD) post hoc testing, as SNK was unable to do
so. The bone volume was higher in the defects grafted
with BCP mixed with blood compared with those
mixed with F127 when exposed to HBO (P .024) but
not for the matching grafts under NBO. No other sig-
nificant differences were seen in this parameter be-
tween the various matched groups.
Defects containing biphasic calcium phosphate had
significantly higher BVF, BMC, TMC, BMD, and
TMD than those containing demineralized bone matrix
under the same experimental conditions (ie, NBO-putty
Table II. Post hoc P values for mCT parameters by
matched groups
Post hoc P values
BV1 BVF BMC2 TMC2 BMD TMD
BCP vs DBM
Putty-HBO .638 .001 .05 .05 .001 .001
Putty-NBO .098 .001 .05 .05 .001 .001
Blood vs F127 putty
BCP-HBO .024 .294 .05 .05 .001 .012
BCP-NBO .459 .991 .05 NSD .026 .045
F127 gel vs putty
DBM-HBO .718 .718 NSD NSD .729 .506
DBM-NBO .522 .829 NSD NSD .775 .693
NBO vs HBO
BCP-blood .661 .671 NSD NSD .206 .232
BCP-putty .249 .152 .05 .05 .015 .087
DBM-gel .661 .611 NSD NSD .905 .233
DBM-putty .896 .896 NSD NSD .968 .087
Following a significant result in the 1-way ANOVA, the matched
groups within each of the 4 different experimental conditions (BCP
versus DBM, HBO versus NBO and 2 different formulation compar-
isons blood versus F127 putty with the BCP group and F127 gel
versus F127 putty within the DBM group) were tested for significant
differences using a post hoc test.
ANOVA, analysis of variance; BV, bone volume; BVF, bone volume
fraction; BMC, bone mineral content; TMC, tissue mineral content;
BMD, bone mineral density; TMD, tissue mineral density; BCP,
biphasic calcium phosphate; DBM, demineralized bone matrix; NBO,
normobaric oxygen; HBO, hyperbaric oxygen; NSD, not significantly
different.
1Following a significant ANOVA test, none of the group comparisons
for the BV were found to be significant by Student-Newman-Keuls
post hoc testing. We therefore used Fisher’s least significant differ-
ence (LSD) method to identify differences.
2P values were not obtained from post hoc testing of non-normal data
and are reported as .05 if they were found to be significantly
different, or NSD if there were not.and HBO-putty) (P  .05).HBO reduced BMC, TMC, BMD and TMD in the
BCP-putty treated defects, but not the defects filled
with BCP mixed with blood. HBO did not alter any of
the other parameters in any of the other groups.
Defects grafted with BCP mixed with blood com-
pared with BCP mixed with F127 had significantly
higher BMC, BMD, and TMD under NBO and HBO
conditions. The amount of F127 mixed with DBM had
no significant effects on any of the parameters mea-
sured.
Histological analysis
The DBM- and BCP-filled defects each had their
own unique histological appearance (Fig. 1, A and B).
The DBM gel- and putty-filled defects revealed the
same microscopic features. All defects were bridged
with a mixture of bone and residual bone substitute
Fig. 1. A, Montage of photomicrographs covering an entire
calvaria grafted with DBM gel and putty. Rabbit was exposed
to HBO treatment. Bone bridges the entire defect resulting in
complete union. (Hematoxylin and eosin, [H&E], original
magnification of each photomicrograph 4.) B, Montage of
photomicrographs covering an entire calvaria grafted with
BCP and BCP putty from a rabbit exposed to HBO treatment.
Because of decalcification, the residual graft has been re-
moved and so appears as voids in the defect. The defect is
completely bridged by bone along its dural aspect. New bone
and marrow elements are most common at the margins and
dural aspect, with the tissue along the periosteal aspect being
predominantly fibrous lighter. (H&E, original magnification
of each photomicrograph 4.)(Fig. 1, A).
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some fibrous tissue as well as residual DBM particles
(Fig. 2). Residual DBM contained empty lacunae (Fig.
3). Woven bone bounded the residual DBM and was
lined by cuboidal cells that appeared morphologically
to be osteoblasts (Fig. 3, A and B). New bone formation
was also noted within the DBM particles.
BCP defects revealed similar microscopic features to
DBM defects (Fig. 1, B), although fibrous tissue was
more pronounced and could be found throughout the
defect (Figs. 4 and 5, A and B), while it was limited to
the margins in the DBM groups.
Histomorphometry
One-way ANOVA analysis revealed that there were
significant differences within all parameters measured
(Tables III and IV). Histomorphometric analysis dem-
onstrated that DBM-filled defects had significantly
more new bone (P  .008) and less residual graft (P 
.001) than matching BCP-filled defects. Although
DBM-filled defects exposed to NBO also had increased
marrow and reduced fibrous tissue (P  .001 for both),
when the BCP defects had been exposed to HBO these
differences were abolished. These results also corre-
lated with an observed increase in marrow and reduc-
tion in fibrous tissue in BCP defects exposed to HBO
compared with BCP-grafted defects under NBO condi-
Fig. 2. Photomicrograph of a defect of a rabbit filled with
DBM putty from the NBO group. Extensive marrow (M) and
new bone (NB), which is often apposed to residual DBM, can
be seen throughout the field. (H&E, original magnification
20.)tions.HBO was also seen to lead to a small but significant
increase in the amount of new bone in the DBM-grafted
Fig. 3. A, Photomicrograph of a defect of a rabbit filled with
DBM gel and treated with hyperbaric oxygen. Deposits of
new bone are associated with cuboidal osteoblastlike cells
some of which appear to be becoming entrapped in the bone
matrix. (H&E, original magnification 40.) B, Photomicro-
graph of a defect from rabbit filled with DBM putty and
treated with hyperbaric oxygen. The new bone formed on the
residual DBM can clearly be distinguished from the DBM by
the presence of larger rounded lacunae that contain cells
compared to the elliptical empty lacunae present in the DBM
(H&E, original magnification 40).defects (P  .04). Both marrow and fibrous tissue were
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however, this did not reach significance for either tissue
type.
Histomorphometry was unable to note any signifi-
cant differences between groups grafted with different
formulations of BCP (blood versus F127) or DBM (gel
versus putty) in any of the measured parameters.
DISCUSSION
Bone graft substitutes have been successfully used to
treat defects, avoiding some of the limitations associ-
ated with autogenous bone including donor site mor-
bidity, blood loss, and extended time in surgery. HBO
has been shown to enhance the bony healing of critical-
sized defects in rabbits without bone grafting and may
be useful as an adjunct to bone graft substitutes in
smaller defects.12,13 The use of HBO as a testing mo-
dality may also allow the detection of differences be-
tween bone and various bone substitute materials that
are not evident using other testing methods.
The aim of this study was to evaluate the effect of
HBO on the healing of critical-sized defects in the
presence of 2 commonly used types of bone graft
substitutes, demineralized matrix (DBM) and biphasic
Fig. 4. Photomicrograph of a defect filled with BCP putty
from a rabbit in the NBO group. The large empty voids are
where the biphasic calcium phosphate particles were present.
They were lost during decalcification. New bone, marrow,
and fibrous tissue with a thick cellular infiltration can been
seen apposed to the BCP particles (H&E, original magnifi-
cation 20).calcium phosphate (BCP). We also investigated whe-ther different preparations of these substitutes affected
their performance.
Both bone substitute materials were able to promote
healing of the critical-sized defects. HBO did not sig-
Fig. 5. A, Photomicrograph of a defect filled with BCP Putty
in rabbits kept under normobaric conditions. A small island of
bone can be seen apposed to the missing BCP particle and
surrounded by the highly cellular fibrous tissue (H&E, orig-
inal magnification 40). B, Photomicrograph of a defect
filled with BCP Putty in rabbits kept under hyperbaric con-
ditions. A small island of bone can be seen apposed to the
missing BCP particle and surrounded by marrow and new
bone (H&E, original magnification 40).nificantly increase the amount of bone present in the
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exposed to normal air. This result matches our previous
observations where HBO promoted healing and bone
formation in unfilled defects, but provided no further
increase in bone when used in conjunction with autog-
enous bone grafts.6,10 We did, however, observe a
small but significant increase in new bone with DBM-
grafted defects exposed to HBO.
Exposure to HBO reduced the amount of fibrous
Table III. Histomorphometric analysis
DBM
GEL PUTTY
NBO HBO NBO HBO
NB 36.3  3.0 43.7  4.9 35.1  5.5 44.3  2
M 47.0  5.2 41.7  7.8 50.6  8.7 43.6  5
NBM 83.3  6.1 85.5  3.6 85.8  4.4 87.8  4
FT 13.7  5.1 9.6  3.3 9.8  2.5 7.1  3
RG 2.9  1.8 5.0  1.2 4.4  2.7 5.1  2
All results are reported as percentage area of defect occupied by tis
DBM, demineralized bone matrix; BCP, biphasic calcium phosphate
60% F127 (vol/vol); PUTTY, the DBM or BCP granules were mixed
variance; NBO, normobaric oxygen; HBO, hyperbaric oxygen; NB, ne
graft.
Table IV. Post hoc P values for histomorphometric
parameters by matched groups
Post Hoc P-values
NB M NBM FT RG
BCP vs DBM
Putty-HBO .001 .391 .001 .223 .001
Putty-NBO .007 .001 .001 .001 .001
Blood vs F127 putty
BCP-HBO .782 .666 .843 .868 .991
BCP-NBO .630 .834 .537 .513 .977
F127 gel vs putty
DBM-HBO .877 .633 .642 .415 .978
DBM-NBO .706 .346 .800 .547 .515
NBO vs HBO
BCP-blood .831 .047 .013 .002 .908
BCP-putty .926 .045 .021 .006 .996
DBM-gel .030 .365 .577 .611 .637
DBM-putty .039 .169 .590 .630 .958
Following a significant result in the 1-way ANOVA, the matched
groups within each of the 4 different experimental conditions (BCP
versus DBM, HBO versus NBO and 2 different formulation compar-
isons blood versus F127 putty with the BCP group and F127 gel
versus F127 putty within the DBM group) were tested for significant
differences using a post hoc test.
NB, new bone; M, marrow; NBM, new  marrow; FT, fibrous
tissue; RG, residual graft; BCP, biphasic calcium phosphate; DBM,
demineralized bone matrix; NBO, normobaric oxygen; HBO, hyper-
baric oxygen.tissue in the BCP-grafted defects, and showed a match-ing increase in the marrow component of the repair
tissue. We have previously demonstrated that HBO
treatment results in prolonged increases in vascular
endothelial growth factor (VEGF) expression,7 whereas
others have demonstrated VEGF promotes angiogene-
sis, bone formation, and remodeling,13-15 suggesting
that that HBO may potentially reduce fibrous tissue
formation through promotion of angiogenesis, which
could result in increased marrow.
Comparison of the amounts of new bone in the
DBM-filled defects and the BCP-filled defects indi-
cated more bone and marrow formation in the DBM
group irrespective of HBO or NBO therapy. DBM-
filled defects also revealed less fibrous tissue formation
when compared with BCP-filled defects when treated
under NBO conditions. We did not see any differences
in the repair of defects by different preparations of
DBM (gel versus putty), whereas the different prepa-
rations of BCP (blood versus F127) showed some dif-
ferences in mineralization as assessed by the mCT, but
not by histology.
In conclusion, HBO resulted in small increases in
new bone formation in defects grafted with DBM. In
defects grafted with BCP, HBO resulted in a large
reduction in fibrous tissue and an increase in its replace-
ment with marrow.
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